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1. Introduction 
 
The discovery of molecular targets for the development of new insecticides is critical for 
successful control of a variety of insect pests. The extensive databases for genome sequences 
of insects, microorganisms and viruses provide valuable information for identification of new 
targets. Cell-surface proteins, including biogenic amine receptors, are prime targets for 
insecticides. 
Biogenic amines are important messenger substances and regulators of cell functions. Both 
vertebrates and invertebrates have several biogenic amines, including dopamine, serotonin, 
histamine, and acetylcholine, which exist in both major metazoan groups, namely protostomes 
and deuterostomes. In contrast, noradrenaline and adrenaline occur only in vertebrates 
(Blenau and Baumann, 2001), whereas their presumed invertebrate counterparts, octopamine 
(OA)  and tyramine (TA), are restricted to invertebrates (Roeder, 1999).  
All the catecholamines (so named because they share the catechol moiety) are derived from a 
common precursor, the amino acid tyrosine. Octopamine and tyramine are monoamines 
synthesized from tyrosine. OA is the end product in the synthesis pathway, TA acts as 
precursor for OA synthesis. TA is the direct decarboxylation product of tyrosine. This 
reaction is catalyzed with the tyrosine decarboxylase. OA is produced from TA through the 
action of tyrosine-ß-hydroxylase.  
Biosynthesis of dopamine (DA) also starts from tyrosine, which is converted to 
dihydroxyphenyl- alanine (L-DOPA) by the enzyme tyrosine hydroxylase. Downstream, the 
enzyme dopa decarboxylase catalyzes the conversion of L-DOPA to dopamine. Release of 
these biogenic amines is similar as for most neurotransmitters, they are transported from the 
cytoplasm to specialized storage vesicles. Upon the arrival of an action potential, the influx of 
calcium ions leads to the fusion of vesicles with the neuronal membrane and then vesicles 
discharge their content into the synaptic cleft. Under normal conditions, specialized  
transporter molecules  in the nerve terminals recycle neurotransmitter compounds that have 
been released into the synaptic cleft by pumping them back into the nerve terminal. This 
action is highly effective and compound specific. Interference with reuptake has significant 
effects. Cocaine for example interacts with insect octopamine reuptake, thus inducing 
hyperactivity of the treated insects (Scavone et al., 1994). In vertebrates, cocaine interacts 
with reuptake for dopamine and serotonin, inducing all the known psychotropic effects of this 
compound. 
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The following figure summarizes the biosynthesis of  tyramine, octopamine and dopamine.  
 
Figure 1: Synthesis of TA, OA and DA. 
The amino acid tyrosine is the starting point for the synthesis of these compounds. TA is the direct 
decarboxylation product of tyrosine. This achieved through the tyrosine decarboxylase. OA is produced from TA 
through the tyrosine-ß-hydroxylase. Biosynthesis of dopamine starts from tyrosine which converts to 
dihydroxyphenylalanine (L-DOPA) by the enzyme tyrosine hydroxylase. Dopa decarboxylase then catalyzes the 
conversion of L-DOPA to dopamine.  
 
In insects, biogenic amines act as neurotransmitters, neuromodulators and neurohormones. 
Biogenic amines control endocrine and exocrine secretion, the contraction of muscles, and the 
activity of neurons and in addition they are involved in learning and the formation of memory  
(Schwaerzel et al., 2003; Riemensperger et al., 2005; Unoki et al., 2005). 
Biogenic amines mediate these cellular and physiological effects by binding to specific 
membrane protein that belong to the superfamily of G-protein coupled receptors (Fig.2). It is 
a family that comprises diverse molecules as neurotransmitter receptors, rhodopsin, olfactory 
receptors and cytokine receptors and it includes attractive targets for insecticides. 
 
Figure 2: G-protein coupled receptors 
The polypeptide spans the membrane seven times. The transmembrane regions (TM 1–7) are depicted as 
cylinders. The N-terminus (NH2) is located extracellularly and often contains glycosylated residues (o). The C-
terminus (COOH) is located intracellularly. The membrane-spanning regions are linked by three extracellular 
loops (EL1–EL3) that alternate with three intracellular loops (IL1–IL3). Post-translational palmitoylation of 
cysteine residues (C) in the cytoplasmic tail creates a fourth intracellular loop (IL4) (Blenau and Baumann, 
2001). 
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G-protein coupled receptors or 7TM receptors comprise a large protein family of 
transmembrane receptors that sense molecules outside the cell and activate inside signal 
transduction pathways and subsequent cell responses. The N-terminus is located 
extracellularly, whereas the C-terminus is located intracellularly. The N-terminus is the target 
of a common posttranslational glycosylation. The membrane-spanning regions are linked by 
three extracellular loops (EL) that alternate with three intracellular loops (IL). Cysteine 
residues in the C-terminus of the polypeptides are the target of posttranslational 
palmitoylation. This modification creates a fourth intracellular loop (Horstmeyer et al., 1996). 
A receptor is activated after binding of the specific biogenic amine in a binding pocket formed 
by the TM regions in the plane of the membrane. Individual residues in TM3, TM5, and TM6 
were shown to participate in ligand binding. For positively charged ligands such as biogenic 
amines, negatively charged counter ions inside and close to the binding pocket have been 
identified as crucial for receptor activation. Once the ligand is bound, the receptor changes its 
conformation. This structural alteration usually mechanically activates the intracellular 
trimeric GTP-binding proteins (G proteins) which exchange its bound GDP for a GTP. The 
G-protein's α subunit, together with the bound GTP, can then dissociate from the ß and γ 
subunits to further affect intracellular signaling proteins or target functional proteins directly 
depending on the α subunit type (Gs, Gi or Gq). There are two major signal pathways 
involving the G protein coupled receptors: the cAMP signal pathway and the phosphatidyl- 
inositol signal pathway (Hille, 1994; Clapham and Neer, 1997). 
In the cAMP signaling pathway, GPCR activation leads to subsequent change of intracellular 
messenger concentrations (Fig.3). A change in the intracellular concentration of cAMP and/or 
Ca2+  is most likely to take place. As a result of GPCR activation, cAMP can change in two 
directions: cAMP levels are either elevated or decreased. The cellular response depends on 
the specificity of interaction between the receptor and the G protein (Gudermann et al., 1996; 
Gudermann et al., 1997a; Gudermann et al., 1997b). When the receptor binds to a Gs-type 
protein, the activated Gαs subunit will interact with adenylyl cyclase (AC) in the plasma 
membrane. This leads to an increase of cyclase activity and production of cAMP from ATP 
with the help of cofactor Mg2+ or Mn2+. The rise in cAMP will then activate cAMP-dependent 
protein kinase (protein kinase A, PKA). Phosphorylation of serine and/or threonine residues 
by PKA modifies the properties of various substrate molecules including cytosolic proteins, 
ligand-gated and voltage dependent ion channels, as well as transcription factors, such as 
CREB, CREM, and ATF-1 (De Cesare et al., 1999). Several biogenic amine receptors are also 
known to inhibit adenylyl cyclase activity. This effect is mediated by interaction of the 
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receptor with inhibitory G proteins (Gi). Interaction of adenylyl cyclase with activated Gαi 
subunits most likely competes with binding of activated Gαs subunits and thereby interferes 
with cyclase activation. 
 
 
Figure 3: Biogenic amine receptors coupled to intracellular cAMP signaling pathways 
  A: Biogenic amine receptors are activated by binding of agonists (ligand, Lig). The ligand bound receptor then 
activates a stimulatory G protein (Gs), which leads to an increase in the enzymatic activity of adenylyl cyclase 
(AC). Adenylyl cyclase catalyzes the conversion of ATP to cAMP. As the intracellular concentration of cAMP 
increases, cAMP-dependent protein kinase (PKA) is activated and phosphorylates different target proteins on 
serine and threonine residues. B: Several biogenic amine receptors are known to inhibit AC activity via 
inhibitory G proteins (Gi). 
 
Another pathway that is activated by several biogenic amine receptors results in an increase of 
Ca2+. In this case, the amine-activated receptor binds to G proteins of the Gq/o family 
(Gudermann et al., 1996; Gudermann et al., 1997a; Gudermann et al., 1997b). The activated 
Gαq/o subunits bind to and stimulate phospholipase C (PLC) activity (Rhee and Bae, 1997). 
The enzyme hydrolyzes phosphatidylinositol 4,5-biphosphate into two second messengers, 
IP3 and DAG (Fig. 4). The IP3 freely diffuses and binds to specific IP3 receptors on the 
membrane of intracellular Ca2+ stores (endoplasmic reticulum and metochondria). These 
receptors are second messenger-gated Ca2+ channels. Therefore, after binding of IP3, the 
channel pore is opened and Ca2+ is released into the cytoplasm. Ca2+ ions play a pivotal role 
in the regulation of many cellular functions by directly controlling enzymatic or ion channel 
activities. Furthermore, Ca2+ can also bind to members of the large family of Ca2+ - binding 
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proteins (calmodulin, calbindin, calretinin, etc.) that modulate the activation properties of 
many effector proteins by protein-protein interaction. Since PLC not only generates IP3 but 
also DAG, receptor coupling to Gq/o proteins might activate a second signaling pathway in 
addition to Ca2+ release. DAG remains associated with the membrane, where it activates 
protein kinase C (PKC).  PKC enzymatic activity requires the presence of DAG and Ca2+ as 
well as association of the kinase with the membrane. Similar to PKA, PKC phosphorylates a 
variety of proteins on serine and threonine residues, which alters the functional properties of 
these proteins, changing their catalytic activities leading to cellular responses. 
 
 
Figure 4: Biogenic amine receptors coupled to intracellular IP3/DAG signaling 
pathways. 
Agonist (ligand, Lig)-bound biogenic amine receptors activate G proteins of the Gq/o family (Gq/o) that regulate 
the enzymatic activity of phospholipase C (PLC). This enzyme hydrolyzes phosphatidylinositol 4,5- 
bisphosphate into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). Binding of IP3 to specific 
receptors (IP3- R) that form ion channels in the membrane of the endoplasmic reticulum (ER) causes release of 
Ca2+ into the cytoplasm. Both the increase in intracellular Ca2+ and the membrane bound DAG activate protein 
kinase C (PKC) that phosphorylates different target proteins.  
 
 
Biogenic amines have many functions controlling all phases of the life cycle of an insect. 
They are important chemical messengers during embryonic and larval development and they 
participate in the synaptic organization of the brain in the adult. As neuroactive substances 
they act on sensory receptors, inter- and motor neurons, and muscles and other peripheral 
organs  such as fat body, salivary glands, corpora allata and corpora cardiaca, oviduct, etc. 
(Rachinsky, 1994; Park and Keeley, 1998; Walz et al., 2006; Rauschenbach et al., 2007). 
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Biogenic amines can initiate or modulate different types of behaviour and they are involved in 
learning and the formation of memory in insects. The effects of biogenic amines in the insect 
central nervous system are studied with many techniques including cell cultures, 
microinjections of amines and receptor ligands, and behavioural assays. Often the 
physiological responses to biogenic amines last for many minutes, which suggest that they 
may be act as neuromodulators. Biogenic amines modulate neuronal activity and the efficacy 
of synaptic transmission in all parts of the nervous system. The huge projection fields of many 
aminergic neurons support the idea of parallel modulation of entire neuronal circuits by just a 
few aminergic cells. In addition to synaptic neurotransmission, some aminergic neurons 
release the amine into the heamolymph (Hauser et al., 2006). The substances are transported 
throughout the body and may thus have hormonal functions in specific target tissues. 
 
1.1. Octopamine and tyramine 
 Octopamine has been identified almost 60 years ago in the salivary glands of Octopus 
(Erspamer, 1952). Starting from this, it has been identified in countless invertebrates, in the 
central nervous system, but also in peripheral organs (Roeder, 1999). The physiological role 
of octopamine at different levels of the organism is not completely documented. As a stress 
hormone in the periphery and in the central nervous system OA prepares the animal for 
energy-demanding behaviors such as aggression and stress resistance (Mercer and Menzel, 
1982; Adamo et al., 1995; Scholz et al., 2000; Stevenson et al., 2000; Schwaerzel et al., 2003; 
Schroll et al., 2006; Vergoz et al., 2007; Hoyer et al., 2008). This monoamine stimulates 
glycogenolysis, modifies muscle contraction, supports long-term flight, and regulates 
“arousal” in the central nervous system (Brembs et al., 2007). Injection of OA can elicit flight 
motor behaviour in locusts. It is assumed that in insects OA has functions similar to those of 
the adrenergic system in vertebrates (Roeder, 1999). OA can modulate sensory receptors and 
receptor organs in insects. In many cases the sensitivities of the receptors are enhanced. The 
octopaminergic neurons are known to innervate most of the larval muscles (Monastirioti et 
al., 1995). The amplitude of  neuromuscular junction potential is increased by applying  
octopamine in a dose- dependent manner (10 -7 to 10-5 M) up to 115% compared with the 
control (Nagaya et al., 2002). Different functions of octopamine and tyramine at the sensory 
periphery are not very well understood, because the two amines often differ only in the degree 
of modulation. The increased sensitivity of sensory receptors due to the action of OA can 
modify behaviour and is part of the “fight or flight” function. Studies on the Drosophila 
tyramine receptor mutant hono suggest that TA can also modulate the sensitivity of olfactory 
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receptor cells, thus modulating behavioural responses to olfactory repellents  (Kutsukake et 
al., 2000). The modulation of interneurons or effector neurons by biogenic amines is another 
level of modifying signal processing. OA usually enhances the sensitivity or activity of single 
neurons. This effect, which can be measured at both the behavioural and the single cell level, 
is dependent on the state of the insect. OA can induce a state of “arousal” in inactive animals 
and has only minor effects on very active animals. We have only very limited information 
regarding non-neuronal tissue expression of TA/OA receptors. Muscular systems 
(Monastirioti et al., 1995) including ovaries (Lee et al., 2003) as well as malpighian tubules 
are among them (Blumenthal, 2003). But the full picture of the TARs/OARs expression 
pattern in neuronal and non-neuronal tissues does not exist until now. 
  
1.2. Pharmacology of octopamine and tyramine receptors 
A wealth of information is available for the OARs, for which hundreds of different 
compounds display high-affinity properties. Most OARs ligands are agonists and very few are 
antagonists. The attention of pharmacologists was directed to OAR pharmacology after it 
became apparent that these receptors are preferentially present in invertebrates, therefore 
serving as ideal targets for specific insecticides. The imbalance between agonists and 
antagonists may reflect the observation that octopaminergic insecticides are always OAR 
agonists and never antagonists.  
On the basis of OA structure, substances such as synephrine were characterized by their 
higher affinity. The first agonists with high insecticidal potential were the formamidines, with 
chlordimeform as the prototype. Subsequently, additional compounds such as the 
phenyliminoimidazolidines or aminooxazoline derivatives were developed. They displayed 
extremely high affinities for OARs (Long and Murdock, 1983; Nathanson, 1985; Roeder and 
Nathanson, 1993; Roeder et al., 1998). Some of these substances display a high insecticidal 
potency, but only “old” octopaminergic insecticides such as amitraz or chlordimeform were 
used for this purpose. A characteristic feature of these octopaminergic insecticides is the way 
insects react if they are exposed to them. Usually, at rather low doses, the compounds induce 
hyperactivity, which is often followed by the famous leaf walk-off syndrome. Insects feeding 
on leaves are usually too “nervous” to stay where they are; they stop feeding and finally walk 
off the leaves, presumably induced by a higher motor activity. At higher concentrations, this 
hyperactivity can induce tremors that lead to death but knowledge regarding the actions of  
octopaminergic antagonists is limited (Roeder, 2005). 
PDF created with FinePrint pdfFactory trial version http://www.pdffactory.com
Chapter 1: Introduction 8 
Only one antagonist, epinastine, combines high affinity with high specificity and has a 
relatively broad pharmacological spectrum in vertebrates. In insects, it has a narrow 
pharmacological profile, which allows for specific blockades of octopaminergic 
neurotransmission. This makes it an ideal tool for the dissection of octopaminergic 
neurotransmission in vivo (Roeder et al., 1998), a feature that was used to elucidate some 
aspects of octopaminergic neurotransmission (Pophof, 2002). 
Similarities between the octopaminergic/tyraminergic and the adrenergic system are not only 
in the structure of the transmitters/hormones themselves but also in the structural and 
pharmacological features. Although OARs/TARs and adrenergic receptors are homologous 
but their pharmacological characteristics are different, giving enough room for the 
development  of specific insecticides (Roeder, 2005). Drosophila Oamb represents the neural 
type OAR, is ubiquitously expressed throughout the animal and may be responsible for most 
if not all actions of OA. In addition, Drosophila Oamb is thought to be the target for 
octopaminergic insecticides (Roeder, 1999, 2005). 
For insect OARs, only the activation of cAMP synthesis and the elevation of Ca2+ 
concentrations are known, presumably via activation of Gs and Gq. Insect TARs are coupled 
to the activation of the Gi protein, inducing the inhibition of the adenylate cyclase. The 
emerging picture of OA and TA signaling is rather simple. OA is stimulatory, whereas TA is 
inhibitory. This means that octopaminergic agonists and tyraminergic antagonists have 
synergistic activities, an aspect that may be relevant to the development of new strategies for 
pest control (Roeder, 2005). 
Numerous pharmacological studies have been performed in locusts in order to classify 
octopamine receptor classes. According to their pharmacological properties and intracellular 
signaling pathways, four different classes were identified: OCT-1, OCT- 2A, OCT-2B, and 
OCT-3 (Evans and Robb, 1993; Roeder, 1999). Activation of OCT-1 receptors induces an 
increase in [Ca2+]i, whereas activation of OCT-2A, OCT-2B, or OCT-3 receptors stimulates 
adenylyl cyclase and leads to increases in [cAMP]i. In comparison to the locust, only a few 
studies were performed in Drosophila and the honeybee to determine the pharmacological 
properties of octopamine receptors (Dudai and Zvi, 1984; Degen et al., 2000).  
 In Drosophila head homogenates, octopamine is a potent stimulator of adenylyl cyclase 
activity (Uzzan and Dudai, 1982). Interestingly, simultaneous application of both tyramine 
and octopamine reduces the effect of octopamine. This observation suggests that tyramine 
activates specific tyramine receptors that inhibit adenylyl cyclase and thereby reduce the 
stimulatory effect of octopamine (Uzzan and Dudai, 1982). In membrane homogenates of 
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honeybee brains, octopamine also stimulates cAMP production (Blenau and Baumann, 2001). 
In addition, injections of octopamine into the antennal lobe of the honeybee, evoke a rapid 
and transient activation of PKA (Hildebrandt and Muller, 1995). The effects of tyramine were 
also tested on membrane preparations from honeybee brain. When tyramine is applied at high 
concentrations, it activates adenylyl cyclase (EC50 of ~2.2 mM) but at low concentrations 
(0.1–1 mM) it attenuates forskolin-stimulated cAMP production (Blenau et al., 2000).  
The Bombyx mori OA receptor isolated from the nervous tissue of Bombyx larvae which is 
nearly identical to OA receptors isolated from Periplaneta americana, Apis mellifera and 
Drosophila melanogaster Oamb, was expressed in HEK-293 cells. OA treatment at 
concentrations 1mM led to an increase in intracellular cAMP concentrations. The OA receptor 
agonist demethylchlordimeform also elevated cAMP levels to the same maximal level 
(approximately 5-fold greater than basal levels) as that induced by OA. By contrast, the 
biogenic amines TA and DA and demethylchlordimeform lacked effect. The OA-stimulated 
increase in cAMP levels was suppressed by antagonists; the rank order of antagonist activity 
was chlorpromazine > mianserin > yohimbine (Ohta, 2009). 
 
1.3. Dopamine in invertebrates 
In both vertebrates and invertebrates, the biogenic amine dopamine is implicated in many 
functions including locomotion, cognition, and development (Civelli, 1993; Civelli et al., 
1993). In vertebrates, dopamine binds to two subfamilies of dopamine receptors: D1- and D2-
like receptors (Kebabian and Calne, 1979). These receptors belong to the family of GPCRs 
and possess different pharmacological and biochemical properties. In humans, D1- and D5-
receptors constitute the D1-subfamily and activate adenylyl cyclase, whereas members of the 
D2-subfamily, i.e., the D2-, D3-, and D4-receptors, either inhibit adenylyl cyclase or couple 
to different intracellular second messenger systems (Jackson and Westlind-Danielsson, 1994; 
Missale et al., 1998; Vallone et al., 2000).  Three different Drosophila dopamine receptors are 
known: DopR1 or DmDop1, also known as dDA1 (Gotzes et al., 1994; Sugamori et al., 1995); 
DAMB or DopR2 (Feng et al., 1996; Han et al., 1996)and D2-like receptors, also called D2R 
(Hearn et al., 2002).  
In Drosophila, high DA concentrations coincide with larval and pupal molts. Reduced levels 
of DA during larval stages lead to developmental retardation and decreased fertility in adults. 
DA expression in non-neuronal tissue, namely the tracheal system, was reported before 
(Hsouna et al., 2007). But the informations regarding DA and DA receptors physiology and 
localization in larvae and adult flies are far from being complete. 
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In mammals, dopamine modulates movement, motivation and cognition. Abnormal functional 
states of the DA system in humans is though to underlie the behavioural abnormalities of 
Parkinson’s disease, Attention Deficit Hyperactivity disorder (ADHD), schizophrenia and 
addiction. 
Parkinson's disease (PD) is a degenerative disorder of the central nervous system due to the 
loss of some dopaminergic neurons that often impairs the sufferer's motor skills, speech, and 
other functions. Parkinson's disease belongs to a group of conditions called movement 
disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement and 
a loss of physical movement in extreme cases (Lang and Lozano, 1998a, b; Jankovic, 2008).  
Although the identification of genes that are responsible for heritable forms of PD has the 
potential to provide insight into the mechanisms of PD, and the interplay between genetics 
and environment in this disorder, little about the biological functions of the genes have been 
identified and how their mutational alteration results in neuronal death. One promising 
approach to this problem involves the use of classical genetic analysis in the fruit fly, 
Drosophila melanogaster. Drosophila has a complex nervous system that consists of 
~100,000 neurons, and includes a subset of ~200 neurons that contain the neurotransmitter 
DA. Although the anatomy of the fly brain and the distribution of DA neurons in the central 
nervous system of Drosophila differ from that of vertebrate brains, many fundamental cellular 
and molecular biological features of neuronal development and function are conserved 
between vertebrates and invertebrates. This conservation makes Drosophila a powerful 
system for basic studies of neuronal development and function and, more recently, studies of 
neuronal dysfunction. Furthermore, the completion of both human and Drosophila genome-
sequencing projects has also revealed that a large fraction of human genes, including many 
involved in disease, have highly conserved counterparts in Drosophila. In particular, the 
Drosophila genome encodes homologs of five out of the six PD-related genes that have been 
identified. The important advantage of using Drosophila as a model for human disease to 
understand is the ability to conduct genome-wide genetic screens for mutations in other genes 
that modulate the phenotype associated with a disease model and identify genetic pathways 
that cause the disease, as well as those that can influence it. 
Humans dopaminergic system has also been implicated in the control of the reward 
mechanisms and in the psychomotor effects generated by drugs of abuse, including opiates, 
cocaine, amphetamine and alcohol (Wise and Bozarth, 1987; Koob, 1992). Cocaine and 
amphetamine increase DA levels in the synaptic cleft by blocking the activity of the DA 
transporter (DAT), and by reversing DA transport via DAT  thus elevate mood and cause 
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pleasure (Wise and Bozarth, 1987). However, opiates have an inhibitory effect on DA release 
in a variety of brain areas including the striatum, frontal cortex, mediobasal hypothalamus and 
amygdala (Wise, 1996). Mutant strains have different responses to the effect of alcohol on 
locomotion. Behaviors are remarkably similar to those described for mammals. Thus 
Drosophila also has been proposed as a model organism for studying the genetics of addiction 
and understanding  the biochemical regulator of  drugs sensitization.  
Few approaches also use Drosophila as a model of studying Attention Deficit Hyperactivity 
disorder or ADHD (De Luca et al., 2002). 
Thus generations of genetically modified Drosophila for different components of the 
dopaminergic pathways constitutes a powerful tool for studying the in vivo roles of these 
proteins.  
 
1.4. The role of OA and DA in learning and memory 
Biogenic amines are involved in different forms of learning and memory formation in 
Drosophila and honey bees. Research on the neuronal and molecular bases of learning and 
memory since many years ago in insects has focused on the mushroom bodies and antennal 
lobes of the brain. These two structures are involved primarily in processing olfactory stimuli. 
Experimental evidence suggests that DA signals the presence of reinforcers and modulates 
intrinsic mushroom body neurons during conditioning in Drosophila. Thus DA could trigger 
signaling cascades that affect the storage of information about the conditioned stimulus. In the 
honey bee, OA appears to be the modulatory transmitter which conveys information about 
rewarding sucrose stimuli and induces medium- to long-term modifications in interneurons 
during associative olfactory learning. Electrical stimulation of an identified octopaminergic 
cell, the ventral unpaired median VUMmx1 neuron, can substitute for the sucrose reward 
during olfactory conditioning (Hammer, 1993). This neuron has extensive arborizations in 
different brain regions, including the antennal lobes and the mushroom bodies. 
Microinjections of OA into these two neuropiles of the bee brain confirmed that OA in fact 
induces associative learning. Thus, a picture emerges, where aversive learning depends on 
dopamine, whereas reward learning depends on octopaminergic signalling. In both cases, the 
mushroom bodies are essential integrative centres for these rather complex behaviours. The 
exact molecular and cellular substrates underlying this very interesting behaviour are 
nevertheless not understood yet. 
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 1.5. Drosophila tools used in neurobiology 
A very useful genetic tool for study of gene function in Drosophila is the P-element 
transposition system (Rubin and Spradling, 1982). P-elements have been utilized to knock out 
genes as well as to insert genes into the Drosophila genome. This allows the study of 
genetics, developmental biology, neurobiology, and medicine.  
Drosophila provides an excellent model system to study of biogenic amines and their 
receptors due to the availability of various mutant lines, driver lines and effector lines that are 
specific for amine systems. Driver lines and effector lines are the two essential components 
make the binary system GAL4/UAS system (Brand and Perrimon, 1993b). With the 
GAL4/UAS system (Fig.5) genes can be expressed in temporally and spatially restricted 
manner. 
 
Figure 5: The bipartite UAS/GAL4 system in Drosophila 
When females carrying a UAS responder (UAS-GFP) are mated to males carrying a GAL4 driver , only  progeny 
containing both elements of the system express the responder in a transcriptional pattern that reflects the GAL4 
pattern of the respective driver  (modified from (Duffy, 2002). 
 
  
To learn more about the physiological relevance of a certain gene, constructs carrying the 
gene of the yeast transcription factor GAL4 can be inserted in the Drosophila genome. In 
these line, which are called driver lines, GAL4 expression is driven by promoters previously 
cloned upstream of the GAL4 gene and subsequently inserted into the Drosophila genome by 
germline integration. Independent from these lines are other transgenic lines that allow 
targeted overexpression of any gene of interest. There, the GAL4 binding site (UAS) with 
many options of reporter genes are produced. The gene of interest is under transcriptional 
control of GAL4, meaning that it is only expressed if Gal4 is present. Thus, crossing these 
two lines will bring both partners, Gal4 and UAS element, together in the F1 generation, but 
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only in those cells, where the corresponding promotor is active. This yields a targeted 
expression pattern totally depending on the expression pattern of the driver line. Countless 
different combinations of crossing are possible, which combine a wealth of different driver 
lines with different anatomical localizations (e.g. only in the brain or only in the muscles) 
with also countless different effector lines (e.g. GFP or overexpression of human diseases 
relevant proteins etc.). A recent and extremely versatile update of the Gal4/UAS system has 
been the introduction of UAS-RNAi lines that allow targeted down regulation of any gene of 
interest. These lines contain a double-stranded hairpin construct under UAS control. Even 
more versatile was the introduction of a series of 22.000 transgenic lines covering the almost 
entire genome, which has been made available to the public via the Vienna Drosophila 
Research Center (Dietzl et al., 2007). 
The information regarding the expression pattern of biogenic amine receptors within the 
different insects tissues (including CNS) are very important from different points of view and 
has important implications for comparative and evolutionary physiology and biochemistry as 
well as serving as new targets for insecticides. Numerous data have been collected but the 
data are not complete, thus there is a growing need for these informations to be used for 
further, downstream studies and applications. To fill this gap, the physiological relevance of 
the different receptors has to be elucidated. As already pointed out, the fruit fly Drosophila 
melanogaster is ideally suited for this purpose, because it can be manipulated with great ease 
and speed.         
To get access to the pharmacological properties of biogenic amine receptors, their 
heterologous expression in cell culture systems is required. To achieve this, full-length clones 
of all relevant genes coding for these receptors have to be cloned into mammalian expression 
vectors to get stable cell lines expressing the receptor of interest. Followed by artificial 
application of different lead compounds for insecticide into cells, including agonists and 
antagonists, reporter assay have to be optimized to allow in depth pharmacological studies. 
Those receptors that are most promising should be made available for high-throughput or 
semi-high-throughput screening assay systems. 
 
1.6. Aim of the work 
The main goal of this work was to get more accurate knowledge about the expression and 
function of the biogenic amine receptors in the fruit fly Drosophila melanogaster especially 
for TARs/OARs and DA receptor members. The present study has three main aspects: 
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1.  Characterization of the temporal and spatial expression pattern of each of biogenic amine 
receptors using the binary system GAL4/UAS (Brand and Perrimon, 1993a). GAL4- 
transgenic lines carrying promoters’ sequence of each bioamine receptor gene should be 
constructed by germline integration. These promotor-GAL4 lines should be used, together 
with corresponding UAS-GFP responder lines to elucidate the expression patterns in all 
developmental stages (larvae, pupae and adults) and in all organs in detail. 
2. The major question is: Which receptor represents a potential target for insecticides. RNAi-
based silencing and overexpression studies for biogenic amine receptors using 
GAL4/UAS system by which it is possible to interfere with gene function practically 
anywhere and anytime during development. RNAi experiments will be performed with 
different types of RNAi lines covering all genes of interest. Using them a number of 
phenotypical and/or behavioural parameters should be quantified.  
3. Pharmacological characterization of biogenic amine receptors. 
To achieve this, full-length clones of genes coding for biogenic amine receptors are 
cloned into mammalian vectors. Following this, stable transgenic cell lines are established 
that express each gene coding for a biogenic amine receptor. Application of different lead 
compounds for insecticides should unravel the pharmacological features of these very 
important molecules. 
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2. Materials and methods 
2.1. Materials 
2.1.1. Drosophila lines 
2.1.1.1. GAL4-Lines (Bloomington stock centre http://flystocks.bio.indiana.edu/). 
§ Y [ 1]W[*]; P{w [+mC] =tubP-GAL4}LL7/TM3, sb [1]. 
 
2.1.1.2. UAS-lines (Bloomington stock centre) 
§ P {w[+mc]+UAS-mCD8:GFP.L}LL4, y[1]w[*] P{w[+mW.hs=GawB}Iz[gal4] 
 
2.1.1.3. RNAi-lines (Bloomington stock centre) 
§ CG33976: Dm Octbeta2R 
 
2.1.2. Buffers and solutions 
§ Drosophila Ringer’s solution: CaCl2.2H2O 3mM, KCl 182mM, NaCl 46mM and Tris 
base 10mM were dissolved in distilled water. The pH value was adjusted to 7.2 with 
1N HCl and the solution was filtered using filter paper with 0.47mm pores and 
autoclaved. 
§ Phosphate buffered saline (PBS): NaCl 137mM, KCl 2.7mM, Na2HPO4 4.3mM and 
KH2PO41.47mM, were dissolved in 500 ml distilled water, adjusted to pH 7.5 and 
diluted up to 1L (1x). 
§ SOB-medium: 20g bacto tryptone  and 5g bacto yeast extract were dissolved in 900ml 
distilled water; 2ml of 5M NaCl, 2.5ml of 1M KCl, 10ml of 1M MgCl2 and 10ml of 
1M MgSO4 were added. The solution was diluted up to 1L with distilled H2O and 
autoclaved. 
§ Paraformaldehyde in PBS (4%): 4g of paraformaldehyde were dissolved in 100ml 
Phosphate Buffered Saline (PBS) with aid of a hotplate stirrer. The solution was 
become clear on cooling before being stored at 4°C. 
 
2.1.3. Chemicals 
Agar                                                                                                                Carl Roth Hamburg,Germany  
Agarose                                                                                                    Biozym (Hamburg,Germany)  
Ampicillin Sodium salt                                                                                  Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Boric acid                                                                                                         Carl Roth (Hamburg,Germany)   
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Calcium chloride                                                                                                          Carl Roth (Hamburg,Germany)   
Diethanolamine                                                Acros Organics GmbH (Taufkirchen)  
Dimethylsulfoxide (DMSO)                                                            Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Disodium hydrogen phosphate                            Carl Roth (Hamburg,Germany)  
dNTP                                                                                               MBI Fermentas GmbH ( St.Leon-Rot)      
EDTA                                                                                                       Applied Biosystems (Darmstadt)  
Ethanol                                                                                                      Carl Roth (Hamburg,Germany)  
Ethidium bromide                                                                                    Applied Biosystems (Darmstadt)  
Glucose                                                                                                            Carl Roth (Hamburg,Germany)  
Goat serum Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Hoechst stain Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Isopropanol                                                                                                      Carl Roth (Hamburg,Germany)  
LB-agar                                                                      Invitrogen Life Technologies (karlsruhe)  
LB-medium                                                                                             Invitrogen Life Technologies (karlsruhe)  
Magnesium chloride                                                                                                                   Carl Roth (Hamburg,Germany)   
Magnesium sulphate                                                                                        Carl Roth (Hamburg,Germany)   
Napagin  Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Nile red  Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Paraformaldehyde                                                                                 Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Peptone Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Phalloidin                                                                                                                Sigma-Aldrich chemicals GmbH (Taufkirchen)  
PNP (P- Nitrophenyl phosphate tablets)                                Sigma-Aldrich chemicals GmbH (Taufkirchen)  
RNA magic                                                                                           Bio-Budget (Hamburg,Germany)  
Sodium chloride                                                                                               Carl Roth (Hamburg,Germany)  
Sucrose                                                                                                             Carl Roth (Hamburg,Germany)  
Tris Sigma-Aldrich chemicals GmbH (Taufkirchen)  
TritonX-100 Sigma-Aldrich chemicals GmbH (Taufkirchen)  
X–GAL                                                                                                          Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Yeast extract Sigma-Aldrich chemicals GmbH (Taufkirchen)  
Zink chloride                                                                               Carl Roth (Hamburg,Germany)  
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 2.1.4. Compounds used in pharmacological experiments (obtained either from Sigma-
Aldrich chemicals GmbH (Taufkirchen) or from different researchers). 
Amitraz (N,N'-[(methylimino) dimethylidyne]di-2,4-xylidine) 
Chlordimeform.                                                                                       
Chlorpromazine (3-(2-chloro-10 H-phenothiazin-10-yl)-N, N-dimethyl-propan-1-amine )                                                                                                         
Desmethylchlordimeform 
Dopamine (4-(2-aminoethyl) benzene-1,2-diol)                                             
Epinastine  
Mianserin (RS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine )                                                                                                      
Metoclopramide monohydrochloride(4-amino-5-chloro-N-(2- (diethylamino)ethyl)-2-
methoxybenzamide )   
Naphazoline hydrochloride (2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole )                                                                                                     
NC3 
NC4 
NC5 
NC6 
NC7 
NC9 
NC12 
Octopamine (4-(2-amino-1-hydroxy-ethyl)phenol)                                       
Phentolamine (3-[4,5-dihydro-1H-imidazol-2-ylmethyl- (4-methylphenyl)-amino]phenol)                                                                                              
Rauwolscine                                                                                                   
Serotonin (5-Hydroxytryptamine or 3-(2-aminoethyl)-1H-indol-5-ol )      
Synpherine (4-[1-hydroxy-2-(methylamino)ethyl]phenol)                           
Tyramine (4-(2-aminoethyl)phenol)                                                             
Yohimbine hydrochloride (17α-hydroxy-yohimban-16α-carboxylic acid methyl ester)                                                                                       
 
2.1.5. Kits 
DNA purification kit         MBI Fermentas GmbH ( St.Leon-Rot)      
Plasmid preparation kit          Mol Biotech (Heidelberg, Germany)       
PCR purification kit MBI Fermentas GmbH ( St.Leon-Rot)      
SEAP assay Kit Invitrogen Life Technologies (karlsruhe)  
Gel extraction kit MBI Fermentas GmbH ( St.Leon-Rot)      
The CloneJET™ PCR Cloning Kit MBI Fermentas GmbH ( St.Leon-Rot)      
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2.1.6. Drosophila media 
 Semi-defined medium:10g agar, 80g yeast, 20g yeast extract, 20g peptone, 30g sucrose, 60g 
glucose, 0.5g MgSO4.6H2O and 0.5g CaCl2.2H2O were dissolved into 1L with water, boiled 
and cooled to 60°C. Propionic acid and Napagin were added during stirring. The mixture was 
dispensed when the temperature reached 40-50°C. 
 
2.1.7. Cell culture media 
Advanced DMEM, Dulbecco’s modified Eagle medium, was used. It was supplied with L-
glutamine or GLUTAMAX™-I (GIBCOâ). Twenty ml of fetal bovine serum albumin, 5ml 
GLUTAMAXTM and 5ml penicillin/streptomycin were added to each 500 ml bottle. 
 
2.1.8. Enzymes 
§ Superscript                                                       Invitrogen Life Technologies (karlsruhe)        
§ T4 DNA Ligase                                                   MBI Fermentas GmbH ( St.Leon-Rot)       
§ Taq Polymerease                                                  MBI Fermentas GmbH ( St.Leon-Rot)       
§ CIAP                                                                    MBI Fermentas GmbH ( St.Leon-Rot)       
§ Retriction enzymes were from MBI Fermentas GmbH ( St.Leon-Rot).       
 
2.1.9. Plasmids 
§ pCRE-SEAP                                                      BD Bioscience Clontech (Heidelberg) 
§ PpTGAL                                                                                     (Provided by D. Eberl) 
§ pEAK10CV                                                       Edge Biosystems (Gaithersburg, USA) 
 
2.1.10. Antibodies 
2.1.10.1. Primary antibodies 
§ anti GFP(1A5) - Rat monoclonal IgG    Santa Cruz Biotechnology (Heidelberg, 
Germany) 
§ N2 7A1 ARMADILLO- Mouse Anti-Drosophila Armadillo Protein Monoclonal 
Antibody, Unconjugated.           Developmental Studies Hybridoma Bank (Iowa, USA) 
§ Prospero (MR1A) - Mouse Anti-Drosophila Prospero Protein Monoclonal Antibody, 
Unconjugated.                            Developmental Studies Hybridoma Bank (Iowa, USA) 
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2.1.10.2. Secondary antibodies 
§ DyLightTM 488-conjugated Affinipure Donkey Anti-Rat IgG (H+L)  
Jackson ImmunoResearch Europe (Heidelberg, Germany). 
§ DyLightTM 549-conjugated Affinipure Goat Anti-Rat IgG (H+L)  
Jackson ImmunoResearch Europe (Heidelberg, Germany). 
 
2.1.11. Oligonucloetides (primers) 
2.1.10.1. Primers for biogenic amine receptor gene promoters amplification 
DOPR1-sense: 5`-GAG AGC GGCCGCATGGAG CTT TGG AGG TTT-3` 
DOPR1-antisense: 5`-GAGAGG ATC CAC ACA CAC TTA CAC GTC ACT-3` 
DOPR2-sense: 5`- GAG AGC GGC CGC TAA CTC GAT TCT CGC ATGC-3` 
DOPR2-antisense: 5`-GAG AGA TCT CTG TTC CTG TGC CTG ATT CT-3` 
DOPR2-like-sense: 5`- GAG AGC GGC CGC AGT TGT TCG TTG TGG TGT-3` 
DOPR2-like-antisense: 5`- GAG AGA TCT CAG CCA CAT TGT CCA G-3` 
OAMB –sense: 5`-GAG GCG GCC GCT GTA TGA GTG GTG CCA CAGC-3` 
OAMB-antisense: 5`-GAG AAGATCTAATTGTT CGTT CCGGAACG-3` 
OA2- sense: 5`- GACGAC CTC CAT TTA ACA CC-3` 
OA2-antisense: 5`- TTC CTA GAA CCC AAC ATGCC-3` 
OCTBeta 2R- sense: 5`- GAG AGG ATC CGG CAT CTT CGG TCC AAT ACC-3` 
OCTBeta 2R-antisense: 5`- GAG AGC GGC CGC GAG TCT CGT TGT CTG GTT-3` 
OCTBeta 3R-sense: 5`- GAG AGG ATC CAA TAA TCG GCG AGT GTG AGG-3` 
OCTBeta 3R-antisense: 5`- GAG AGC GGC CGC CCA TGC GAG CCT GAT TAGG-3` 
TyRIII-antisense (BamHI):5`-  GAG AGG ATC CGG TTC ACA ATC GAG TGT GG-3` 
TyrR III –sense (Not I) :5`- GAG AGC GGC CGC CTA ATG CCG GAG ATG AGT GC-3` 
TyrRII -antisense (BglII):5`GAG AAG ATC TGC GGA TAG CTC ACT CAC TTA GG-3` 
TyrRII –sense (NotI):5`GAG AGC GGC CGC AAC GAA TCC TGC TGA CAA GC-3` 
TyrR-antisense (Bgl II):5`GAG AAG ATC TAA CTT TAG CCA CCC GCA AC -3` 
TyrR-sense (Not I):5` GAG AGC GGC CGC CTT GCT GAT GCT CTG GTT GG-3` 
 
2.1.11.2. Primers for amplification of the whole coding regions of biogenic amine 
receptor genes for pharmacological studies 
OCTBeta 2R-cDNA-sense: 5`-GAG AGA ATT CAT GTT GTT GTG CGA CGG CTTG-3` 
OCTBeta2R-cDNA-antisense: 5`-GAG AGC GGC CGC TTA TAA GTT GTC CAC CAT 
CTGA GAC-3` 
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OCTBeta3R-cDNA-sense:5`-GAG AGA ATT CAT GTCAGG GGT TAA CGT GGC TG-3` 
OCTBeta3R-cDNA-antisense: 5`- GAG AGC GGC CGC TTA GAC GTA GTA GGCG 
TTG TACG-3` 
 
2.1.11.3. Sequencing primers 
 PEAK –rev: 5` -ACC TGT CCC GCC TTGAGCT -3` 
 PEAK- for: 5`- CTC AGA CAG TGG TTC AAAG-3` 
 PpTGAL-rev: 5`-TTA GCG ACG AGT TCA CTT TGC-3` 
 PpTGAL-for: 5`-GTT CAA TGA TAT CCAGTG CAGT-3`   
  
2.1.12. Equipment   
 
2.2. Methods 
2.2.1. Drosophila breeding 
Maintenance and breeding of Drosophila were done in clear plastic vials and bottles without 
lid, but capped with foam bungs (Foam wads or closure). Semi defined medium supply to the 
flies was about one fourth of the bottles and vials. Napagin solution and Propionic acid were 
added to the medium to protect media from being infected. Renewal of Drosophila media was 
done every 1-2 weeks, by anaesthetizing adult Drosophila using carbon dioxide in the old 
bottle or vial for a while and moving adults into the new one.  
 
 
 
 
Incubators 
 Waterbath Thermostat                                         Eppenodrf AG (Hamburg) 
Microscopes · Imager.Z1, Zeiss                         Carl-Zeiss MicroImaging, GmbH 
· Leica TCS SP1 confocal Microsystems          Heidelberg Germany 
· Olympus                                  Olympus Optical Co Europa GmbH 
 
PCR machines bio-Rad Laboratories GmbH  (München)                       
 
Spectrophotometer · NanoDrop(ND-1000UV/Vis-spectralphotometer  Peq (Erlangen) 
· Multiscan MCC/340 P version 2.32 
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2.2.2. Constructing GAL4 transgenic lines 
2.2.2.1. Genomic DNA extraction 
Drosophila larvae (5-10) were grinded in 200ml TE buffer and then added to 400ml lysis 
solution (DNA Extraction kit MBI Fermentas), incubated at 65°C for 5min. 600ml of 
chloroform was added to the pervious solution and gently emulsified by inversion (3-5) times. 
After centrifugation at 10,000 rpm for 2min, the upper aqueous phase containing DNA was 
transferred to a new tube containing 800ml of precipitation solution. This solution was mixed 
gently by several inversions at room temperature for 1-2 min and centrifuged at 10,000 rpm 
for 2 min. Supernatant was removed completely and the pellet was dissolved in 100 ml of 
1.2M NaCl solution by gentle vortex. Cold ethanol was added to precipitate DNA, centrifuged 
at 10,000 rpm for 5min. DNA was washed once with 70% ethanol and eluted in sterile 
deionized water by gentle vortexing. 
 
2.2.2.2. PCR Amplification of promoters 
PCR was used to amplify promoters sequence of each bioamine receptor using a specific pair 
of primers designed for each one of these receptors.  
The reaction is generally composed of: 
10X reaction buffer (without MgCl2)     5μl  
MgCl2 25mM   1.5μl 
dNTP mix (10mM of each dNTP)       1μl  
Taq DNA Polymerase(5U/μl)          0.25μl  
downstream primer (10 um/μl)                 1μl  
upstream primer (10 um/μl)                      1μl  
DMSO (optional)                                 2.5μl  
template DNA (10-100ng/μl)              1-2μl 
nuclease-free water (adjusted  to a final 50μl)       
General Cycle condition: 
Step Temp Duration Cycle number 
Denaturation 94°C 1 min 1 cycle 
Denaturation 94°C 30 sec 
Annealing 50-55°C 30 sec                                  
Elongation 72°C 3 min 
35 cycle 
35 cycles 
Final extension 72°C 10 min 1 cycle 
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Final soak 4°C  hold  
 
2.2.2.3. Agarose gel electrophoresis 
Agarose gels were made with 1% (w/v) agarose in electrophroesis buffer (Tris/Borate/EDTA 
(TBE). To make DNA bands visible for agarose gel electrophoresis, 1ml Ethidium Bromide 
(EtBr) was added. After electrophoresis the gel was illuminated with an ultraviolet lamp and 
photographed by a digital camera.  
 
2.2.2.4. PCR purification 
To each 100ml PCR mixture, 400ml of binding solution were added and mixed. The mixture 
was loaded on the top of spin column, centrifuged at ³12,000xg for 1min and the flow 
through was discarded.  Column was washed using 500ml washing buffer and reinserted into 
empty receiver tube. The column was centrifuged at ³12,000xg for 1min. DNA was eluted 
using hot deionized water and the column was centrifuged at maximum speed for 2min. 
 
2.2.2.5. Restriction digest 
Each promoter was digested twice using two restriction enzymes of StuI, XbaI, SstII, NotI, 
BglII, EcoRI, KpnI, and BamHI, which cut in the multiple cloning site of the vector pPTGAl 
(Fig.6). Plasmids were cut twice with the same two restriction enzymes that were used to cut 
the promoter. 
 
Figure 6: Map and construction of the pPTGAL vector. 
The pPTGAL vector, based on CaSpeR3, contains the Gal4 coding sequences driven by a minimal promoter 
downstream of a multicloning site (MCS) for insertion of enhancer-containing fragments. Unique restriction 
sites (asterisks) include StuI, XbaI, SstII, NotI, BglII, EcoRI, KpnI, and BamHI (modified from Sharma et al. 
,2002).  
 
Restriction enzymes and suggested buffers were used according to the manufacturer’s 
instructions (Fermentas). One unit of restriction enzyme was designed to digest 1μg of DNA 
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in 1 hour at 37°C in 50μl of recommended reaction buffer. One µ calf intestine alkaline 
phosphatase was added to the double-digested plasmid and incubated 1h at 37°C. 
 
2.2.2.6. Ligation of promoters in pPTGAL vector 
T4 ligase joins the 5' phosphate and the 3'-hydroxyl groups of double stranded DNA 
molecules. To estimate the vector and insert concentrations, the Nanodrop spectrophotometer 
was used. Ligation mixture was set up as following: 
200 ng of vector DNA 
600 ng of the insert 
10X ligase buffer                      
1 ml T4 DNA ligase                  
Total volume was completed to 10ml with nuclease free water. The mixture was mixed by 
pipetting. Sticky end ligation reactions were incubated at 4°C overnight. Before 
transformation, the ligase was heat-inactivated by placing tube containing the ligation mix in 
65°C water bath for 10 min.  
 
2.2.2.7. Transformation into E. coli DH5α  
Plasmid DNA can be introduced into bacteria by transformation. Competent E. coli cells 
(stock frozen at -80°C) were allowed to thaw in ice, one to three ml of ligation mixture or the 
control were added to E. coli in a separate tube and the contents of each tube were mixed 
gently, incubated in ice for 5min. Then the tubes were heat-shocked by incubating them in a 
water bath at 42°C for 90 seconds and then on ice. 
 
2.2.2.7.1. Culture medium  
Luria-Bertani (LB) medium was utilized for culturing E. coli transformation and conservation.  
To make LB- plates 20g of premix LB Agar powder, 5.0 g tryptone, 2.5 g yeast extract, 5.0 g 
NaCl and 7.5 g agar were dissolved in 500ml dH2O, heated to boil for 1min while stirring, 
autoclaved and cooled to ~55°C. Ampicillin antibiotic was added under sterile condition (final 
concentration of ampicillin-sodium salt 100 mg/L). A thin layer (5mm) of LB Agar (~10mL) 
was poured into each plate. 
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2.2.2.7.2. Culture conditions 
After ligation and transformation into E. coli, 500~800 ml of LB liquid  medium were added 
and incubated at 37°C with continuous shaking for 30min. The E. coli suspension was spread 
on LB-amp-agar plates, dried, inverted and incubated at 37°C overnight. 
 
2.2.2.8. DNA plasmid preparation  
To obtain cells for plasmid isolation, a single colony was inoculated and cultured in 4ml LB- 
amp liquid medium at 37°C with continuous shaking overnight. Plasmid DNA was purified, 
with kit (Fermentas). Cultures were pelleted by centrifugation at maximum speed for 10 min 
and all traces of medium were removed.  250ml of resuspending solution (50 m/m Tris /HCl 
(pH 8); 10mm EDTA; 100mg/ml RNAase A) were added to the pellet and cells were 
resuspended by vortexing until complete homogeneity. Thereafter, 250ml of cell lysis solution 
(200mM NaCl; 1% SDS) were added and mixed gently without vortexing, incubated at room 
temperature for 5 min. Then 350ml neutralization solution (containing acetate and guanidine 
hydrochloride) were added, mixed gently and centrifuged at maximum speed for 10 min. The 
supernatant was loaded on the top of spin column, centrifuged at ³ 12.000 xg for 1 min; the 
flow through was discarded. The column was washed twice with 70% Ethanol. The plasmid 
was eluted by sterile water and centrifugation at ³ 12.000 xg for 2 min. 
 
2.2.2.9. Sequencing 
I have used sequencing Service supplied by Eurofins MWG operon. The sequences were 
obtained and verified using the alignment software BLAST (http:// 
www.ncbi.nlm.nih.gov/BLAST) of the national centre of biotechnology information (NCBI). 
 
2.2.2.10. Injection of Drosophila embryos 
Drosophila transgenic service supplied by BestGene Inc was used. The Drosophila P-element 
transformation based on the injection of transposon-based construct with the white and/or the 
yellow marker to w1118 or yw host line.  
 
2.2.2.11. Crossing of GAL4 lines with UAS-GFP-line  
Each Gal4 line obtained by germline integration was crossed with a UAS- GFP line.Then the 
F1-generation have been analyzed in detail and phenotypical characteristics have been  
quantified to  elucidate the physiological significance of each  receptor . 
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2.2.2.12. Immunohistochemistry  
2.2.2.12.1. Larval and adult CNS 
The CNS of first generation larvae and adults were dissected in Drosophila Ringer`s solution 
and incubated in 4% (w/v) paraformaldehyde in PBS for 1-2 hours at room temperature. 
Tissues were washed three times 5 min in PBS-T (0.1 % Triton-100) and blocked for 30 min 
in blocking buffer (1x PBS + 2% NP-40 +10% goat serum) at room temperature.  The 
samples were incubated with the primary antibody (anti GFP rat monoclonal IgG; 1: 200 in 
blocking buffer) overnight at 4°C and washed three times for 5 min in PBS-T. Subsequently, 
the samples were incubated with the secondary antibody (donkey anti rat IgG; 1: 500 in 
blocking buffer) for 1-3 hours at room temperature, washed twice for 5 min in PBS-T. Final 
washing in PBS-T + Hoechst staining was done to stain nuclei as well. Tissues were mounted 
directly on slides with one drop of focus clear, incubated for 1-3 h and covered with a cover 
slip. 
 
2.2.2.12.2. Digestive system 
Intact guts were dissected in 1×PBS and fixed at room temperature for 45min in 4% 
paraformaldehyde in 1×PBS. All subsequent incubations were done in blocking buffer 
(1xPBS, 2% NP-40, 10% goat serum). The following antisera were used: Rat monoclonal α-
GFP, 1:300, α-armadillo, 1:20 and α-Prospero, 1: 20. The guts were washed three times with 
PBT. The Secondary antibodies used, were Goat anti-mouse and donkey anti-rat IgG 
conjugated to DyLightTM 488 and DyLightTM 549 (1: 1000). Hoechst stain was used (diluted 
1: 1000 with 1×PBS). Preparations were mounted on slides using glycerol as a mounting 
medium and examined using a zeiss axioimager. 
 
2.2.2.12.3. Muscular system  
Phalloidin is a fungal toxin isolated from the poisonous mushroom Amanita phalloides. 
Phalloidin is able to bind to F-actin in muscle cells. As a result of binding phalloidin, actin 
filament becomes strongly stabilized. Fluorescent conjugates of phalloidin are used to label 
actin for histological applications. 
Phalloidin-TRITC P1951 was used according to the manufacturer instructions to identify 
actin filaments in the constructed lines showing expression in muscular tissue, by which we 
can judge whether the expression occurs in all or only in certain muscles. 
Third instar larvae were dissected in PBS solution on a small silicone plate.  Using forceps, 
the larvae were pinned twice at the anterior and posterior ends. Using scissors, the larvae were 
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splitted along the dorsal midline and gut and other organs were removed. The side walls were 
pinned back to expose the body wall muscles. Following dissection, the dissected larval 
preparation is washed twice with PBS, fixed  with 4% PFA in PBS overnight at 4°C, washed 
three times using PBST. then blocked for 30 min in blocking buffer (1XPBS + 2%NP-40 +10 
%goat serum) at room temperature  Incubation  with the primary antibody (anti GFP rat 
monoclonal IgG; 1: 200 in blocking buffer) was done overnight at 4°C then washed three 
times 5 min in PBST (0,1 % Triton-100). Incubation in the secondary antibody (donkey anti-
Rat IgG; 1: 500 in blocking buffer), mixed with TRITC-labelled Phalloidin (0.5 µg/ml), was 
done for 1-3 hours at room temperature. Then, tissues were washed three times for times 5 
min in PBS-T. Preparations were mounted on slides using glycerol as a mounting medium 
and examined using  a Zeiss axioimager. 
 
2.2.2.13. Immunofluorescence microscopy 
2.2.2.13.1. Confocal microscopy 
Larval and adult brain mounts were imaged using a Leica TCS SP1 confocal microscope. 
Images were exported as tiff-format series using the Leica confocal software. The collected Z-
series were projected into a single plane image using ImageJ, Java-based processing program. 
2.2.2.13.2. Immunoflorescence microscopy 
Third stage larvae and adults were examined with standard fluorescence microscopy 
(imager.Z1, Zeiss). 
 
2.2.3. RNA interference  
Virgin females were collected from the GAL4 driver and UAS stocks and the corresponding 
crosses also performed in reverse orientation. About 10 males and 20 females were placed in 
a small vial  at constant temperature  (27-29°C). The animals were passed daily for 1-2 weeks. 
The flies were allowed to remain in the same vial two days, the use of exchangeable food 
vials provided a continuous food supply and provided the necessary egg collection sites. The 
vials were inspected daily and the  relevant event  and date on which they occur was noted as, 
the beginning of 1st larval instar, 3rd larval instar wandering, prepupation formation, pupation, 
eclosion  and pupal lethality. 
Hatchability was determined as the percentage of eggs collected that produce adults, then 
count number of males and females daily. 
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Fecundity determinations were made using female progeny from the egg collection. Ten pairs 
of flies were mated. Their eggs were collected and scored on the basis of total number of eggs 
laid every day for seven days. 
 
2.2.4. Pharmacological characterization of octopamine receptors in human embryonic 
kidney cells (HEK 293 cells) 
To get access to the pharmacological properties of these very important molecules, their 
expression in cell culture system is required. To achieve this, full-length clones of genes 
coding for bioamine receptors were cloned into mammalian expression vectors. Following 
this, stable, transgenic cell lines were established that express the complete set of these genes  
 
2.2.4.1. Cell culture 
HEK-293 cells were cultured in advanced DMEM supplemented with 4% FBS, 50µ/ml 
penicillin, 50g/ml streptomycin, and 2mM glutamine. Cells were grown in an incubator at 
37°C with humidified 5% CO2 and 95% air. The medium was changed every 2-3 days. 
 
2.2.4.2. Transfection in HEK 293 cells 
Transfection was carried with both, the expression vector pEAK10CV containing the gene of 
interest and the reporter plasmid pCRE-SEAP, where the expression of secreted alkaline 
phosphatase is under transcriptional control of cre-elements. 
I harvested the growing HEK293 cells the day before transfection by removing and discarding 
the culture medium taking care to remove all traces of serum that contain trypsin inhibitors. 
Later, cells were rinsed with 25% (w/v) trypsin – 0.53mM EDTA solution, the flask was 
shaken for several seconds and then incubated at 37°C for up to 5 min to facilitate dispersal of 
the cells. Trypsinization was stopped by adding 5-6 ml DMEM medium. Cells were checked 
using microscopic analysis and further processed only if at least 95% single cells were 
present, if not, vigorously shaking was necessary. Then, cells were aspirated by gentle 
pipetting and putting appropriate aliquots into 96–well plates (150 ml each well). These cells 
were incubated in at 37°C until they nearly reached 60-80% confluency.  
The transfection reaction concentrations that have been used typically was the Turbofect 
transfection reagent. 10–20 μg  DNA, NaCl (final concentration 150mM NaCl), 50 μl Turbo- 
Fect Transfection Reagent were mixed, completed to 2ml with nuclease free water, mixed by 
vortexing, incubated approximately 10 min at room temperature (15–25°C) to enable 
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TurboFect–DNA complex to form, then transferred to the flask, and swirled gently. Cells 
were incubated with complexes at 37°C and 5% CO2 for about 24h. 
 
2.2.4.3. Application of compounds 
Most of applied compounds are not water–soluble, so dimethylsulfoxide (DMSO) was used as 
a solvent for stock solutions. 
Agonists 
An agonist is a type of ligand or drug that binds and activates a receptor. Stock solutions were 
10-1M and then a series of tenfold dilutions with 1×PBS were made ranging from10-3 to10-12 M  
and applied to the 96-well plates including wells without compound application. The plate 
with applied agonists was incubated at 37°C and 5% CO2 for about 24h.  
Antagonists 
A receptor antagonistic is a type of receptor ligand or drug that does not produce a biological 
response itself upon binding to a receptor, but blocks or inhibit agonist-mediated responses. 
Seven antagonists have been applied to HEK 293 cells transfected with each receptor type. 
The antagonist activity is examined as the ability of the antagonist to inhibit an agonist 
induced response. The seven antagonists were epinastine, phentolamine, chlorpromazine, 
metoclopramide, yohimbine, rauwolscine and mianserin, and their activities were examined 
by applying agonist first (10-1 M, octopamine) into the same concentration to all wells of 96-
well plates except wells of the first row which then used as a blank, incubating the plate  for 
30 minutes in 37°C, 5%CO2 incubator and then applying antagonists in ten fold diluted 
concentrations (  10-3 to 10-12 M ). Plates were incubated with applied compounds at 37°C and 
5% CO2 for ~ 24h. The activity was tested 24 hours post-application. 
 
2.2.4.4. SEAP reporter assay  
SEAP is a secreted form of embryonic alkaline phosphatase and thus can easily be detected in 
a sample of culture medium without destroying the cells. SEAP catalyzes the hydrolysis of 
pNitrophenyl phosphate, producing a yellow end product that can be read spectrophotometric- 
ally at 405 nm. 
SEAP quantification 
The protocol was used for 96-well plates. About 1 ml of culture medium of transfected cells 
or control cells were collected and centrifuged 5 min at 10,000 rpm. 500 μl of supernatant 
were transferred to a microfuge tube to eliminate cell debris. About 10 μl of supernatant were 
transferred into a well of a 96-well plate. 10 μl of the control served as a blank. Samples were 
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heated to 65°C for 5-10 min to inhibit endogenous alkaline phosphatases. 50 μl of 1X 
Dilution Buffer, 100 μl of 1X Assay Buffer, 20 μl of 100 mM L-homoarginine and 20 μl H2O 
were added and incubation proceeded at 37°C for 10 min. Then 20 μl of Staining Solution 
was added, incubated at 37°C for 10 min in the dark and taken an initial reading of the OD 
405 by using a Multiscan MCC/340 P spectrophotometer. Then they were reincubated at 37°C 
in the dark and readings were taken every 10 min. 
 
2.2.4.5. RNA extraction 
Drosophila larvae 3-5 were grinded in RNA magic solution and 200ml chloroform was added, 
incubated 10 min in ice, centrifuged for 10 min at 17.000xg. The upper aqueous phase was 
transferred into a new tube and equal amount of isopropanol was added, mixed and RNA let 
to precipitate for 30 min at -80°C, centrifuged at maximum speed for 30 min in 4°C. 
Isopropanol then poured off and the pellet washed twice using 70% alcohol. The pellet let 
dried for 5 min and then dissolved in nuclease free water.  
 
2.2.4.6. cDNA synthesis   
Reverse Transcription (RT reaction) have been done using the total cellular RNA.  2-4 mg 
were used, a reverse transcriptase enzyme (superscript SSII), gene specific primers, dNTPs 
and an RNase inhibitor. The resulting cDNA was used in RT-PCR reaction.  The reaction has 
been done at 42°C for 1 hr. then the reaction heated at 70 °C to inactivate the enzyme before 
using the reaction in RT-PCR. 
 
2.2.4.7. RT-PCR 
The resulting cDNA is used as templates for subsequent PCR amplification using primers 
specific for each gene. RT-PCR was carried out by mixing all reaction components (10X PCR 
buffer, dNTPs, gene specific sense and antisense primers, cDNA template and taq 
polymerease) in one tube prior to starting the reactions. 
 
2.2.4.8. Electrophoresis on agarose gels 
PCR product was checked with 1% (w/v) agarose gel.   
 
2.2.4.9. Restriction digests 
Restriction digests were performed according to the suggestions of the manufacturer. 
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2.2.4.10. Transformation in E. coli cells DH5α 
Competent E. coli cells were used as described before. 
 
2.2.4.11. DNA plasmid preparation 
Using plasmid preparation kit (MBI Fermentas) following the instruction enclosed. 
 
2.2.4.12. Sequencing 
The sequence analysis using the service supplied by MWG eurofin, using sense and antisense 
sequencing primers to sequence each insert twice and the result aligned using the web site 
http://www.biochem.ucl.ac.uk/cgibin/mcdonald/cgina2aa.pl. 
The results of sequencing have been translated into amino acids and compared with the gene 
data bank obtained from the national center of biotechnology informations (NCBI) based on 
the amino acid sequence similarity. 
 
2.2.4.13. Statistical analysis  
Data were evaluated using Prism program.  Sigmoidal dose-response curve were plotted for 
the percentage of the in vitro maximal response to an agonist in the presence or absence of an 
antagonist vs. the logarithm of ligand concentration. There after, statistical values were 
obtained automatically including the EC50 values.  
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3. Results 
 
3.1. Studying spatial and temporal expression pattern of biogenic amine receptors 
3.1.1. Octopamine receptors 
3.1.1.1. Oamb expression analysis 
In Drosophila, the gene octopamine receptor in mushroom bodies is referred by the symbol 
Dmel\Oamb (CG3856). Primers targeting a region of approximately 3kB of the presumptive 
promotor region of the Oamb gene were used to amplify this DNA (Fig.7A). The resulting 
PCR product (Fig.7B) was inserted into the pPTGAL vector, checked by sequencing (Sharma 
et al. 2002) and injected into Drosophila w1118 embryos to obtain suitable transgenic lines, 
which express Gal4 under control of this promotor. The injection itself was performed by the 
BestGene Inc corporation. To identify the expression pattern of the Oamb gene, the 
corresponding lines were crossed to a UAS-gfp line.  
 
Figure 7: Generating Oamb promotor inserted pPTGAL4 vector. 
A, schematic drawing showing Oamb gene model and its products. B, 1% agarose gel showing Oamb promotor 
region amplifies with PCR. C, a part of pPTGAL4 vector with GAL4 coding sequence between minimum 
promotor (hsp70 TATA) and terminal transcription sequence (hsp70 terminaltor). pPTGAl4 vector was prepared 
for ligation by double digestion with NotI and BamHI. D,  schematic drawing for promotor-GAL4 -vector. The 
NotI/BamHI double digested promotor sequence was inserted in the NotI/BamHI double digested pPTGAL4 
vector. 
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Figure 8: GFP expression pattern in Oamb-GAL4/UAS::GFP  larval tracheal system . 
A and  B panel, whole L3 larvae and C-E panels are projections of confocal stacks. C, tracheal branching in the 
larval head.  D, tracheal branches of the tail segments. (as) anterior spiracle. Arrow heads  refer to posterior 
spiracles. E, visceral branches of trachea surrounding the proventriculus. F, visceral branches of trachea 
surrounding the gut. G, posterior spiracle (ps). Scale bar = 200mm. 
 
Larvae of F1 generation showed a strong expression in the terminal branches of the tracheal 
system (Fig. 8), including a lot of visceral branches and transverse connectives which were 
visible through the cuticle of living larvae. 
The tracheal expression can be seen throughout the entire system, but it appears to be 
confined to the terminal branches, omitting the primary and secondary branches. Most 
prominent is the labelling of those branches that directly contact organs, such as the gut (Fig. 
8E, F). In addition, larval salivary gland strongly expressed Oamb (Fig. 9). In larval muscles, 
no obvious signs of expression were present.  
In contrast, distinct Oamb expression was evident in the larval CNS (Fig.10). In the brain 
lobes, Oamb expression was highly enriched in the mushroom body primordia. Three parts of 
the mushroom bodies, the calyx, containing the somata, the pedunculus with its axonal 
projection and the axonal terminals lobes, could be distinguished. Two clusters of positively 
stained somata appeared dorsally in the base of each brain lobe. Their processes were directed 
to the suboesophageal ganglion and connected with transverse connectives forming a ladder-
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like structure. Three Oamb neurons on each side arose from this structure and extended into 
the thoracic-abdominal ganglion, along the parallel longitudinal tracts around the midline.  
 
 
Figure 9: GFP expression in Oamb-GAL4/UAS::GFP  larval salivary glands. 
 
 
In each thoracic neuromere, two pairs of strongly stained transverse Oamb expressing neurons 
could be visualized. One pair with their somata resides at the height of the dorso-lateral traces 
in each neuromere. They send a single transverse axon toward the midline. The somata of the 
other pair are located on the ventro-lateral part. They send an axon outside of the thoracic 
ganglia, projecting via the segmental nerves to the periphery. 
The Oamb gene shows also expression in the adult stage.  Moderate but distinctive expression 
appeared in leg muscles in, coxa (depressor of trochanter), trochanter (redactor muscles of 
femur), femur (depressor of tibia) and the middle part of tibia (depressor of tarsus) of both 
midleg and hind leg (Fig.11). 
Adult brain shows strong Oamb expression in all mushroom body subdivisions (Fig12). In the 
optic lobe, Oamb neurons innervates the outer and inner medulla and the lobula. Along with 
Oamb neurons in the central brain, in the middle region of the suboesophageal ganglion and 
in between the antennal lobes. There is also GFP expression in the medulla, lobula and lobula 
plate of the optic lobes. Distinct Oamb immunoreactivity was evident in the thoracico-
abdominal ganglion, especially in the area between the first and second thoracic ganglion and 
second and third thoracic ganglion and abdominal ganglion.  
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Figure 10: GFP immunoreactivity in the whole-mount CNS of third-instar larva Oamb-
GAL4/UAS::GFP 
A, projection of confocal stacks with maximum intensity. B, projection of confocal stacks with minimum 
intensity. C, close-up view on the thoracic neuromeres; t1, prothoracic neuromere;t2, mesothoracic neuromere; 
t3, metathoracic neuromere. D, close-up view on the mushroom body primordia; α/α´ lobes; ß/ß´ lobes; γ lobe; c, 
calyx.   Scale bar = 100mm. 
 
 
 
Figure 11: GFP expression pattern in leg muscles of Oamb-GAL4/UAS::GFP adults .   
Panel A, showing strong GFP in tibia and moderate GFP in femur and tarsi of the fore leg. Panel B, showing 
GFP in the mid leg muscles. Arrow refers to muscles in tibial region (depressor muscle of tarsus), and panel C, 
GFP in the hind leg muscles, with strong GFP in the femur region.   
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Figure 12: GFP immunoreactivity in CNS of Oamb-GAL4/UAS::GFP  adult stage  
showed in projections of confocal  stacks A –E . 
A, Adult brain with strong GFP in mushroom bodies; α/α` lobes and ß/ß` lobes; p, pedunculi. B, close-up view 
on the middle of protocerebrum; head arrows refer to protocerebral bridge. C,  Area between the antennal lobes 
(al) and in the suboesophageal ganglion (sog); arrow refer to somata. D, compound eye showed Oamb 
immunoreactivity in medulla (me), lobula (lo) and lobula plate (lop). E, Oamb immnuoreactivity in thoracico-
abdominal ganglion; t1, prothoracic neuromere; t2, mesothoracic neuromere; t3, metathoracic neuromere; ag, 
abdominal ganglion. Scale bar = 150mm. 
 
 
 
3.1.1.2. Octß2R expression analysis 
In Drosophila, the gene Octß2R is referred by the symbol Dmel\Octß2R (CG33976). To 
explore Octß2R expression, Octß2R sense and antisense primers were used to amplify the 
Octß2R promotor region (~3200bp). This PCR product was inserted in pPTGAL vector, 
which was used for germline integration. Studying the expression pattern was performed 
using the UAS/GAL4 system. The Octß2R Gal4 line, in which the expression of Octß2R is 
driven in Gal4 expressing cells were crossed to a UAS-GFP line. GFP pattern was analyzed in 
the first generation in detail. 
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Figure 13: Generating Octß2R promotor inserted pPTGAL4 vector. 
A, schematic drawing illustrating  Octß2R gene model and its products. B, 1% agarose gel showing Octß2R 
promotor region amplifies with PCR. C, a part of pPTGAL4 vector with GAL4 coding sequence between 
minimum promotor (hsp70 TATA) and terminal transcription sequence (hsp70 terminaltor). pPTGAl4 vector 
was prepared for ligation by double digestion with NotI and EcoRI. D, schematic drawing for promotor-GAL4 -
vector. The NotI/EcoRI double digested promotor sequence was inserted in the NotI/EcoRI double digested 
pPzTGAL4 vector. 
 
 
Larvae show very strong Octß2R expression in the muscular system, including longitudinal, 
transverse, oblique, and acute muscles in both dorsal and ventral regions, which are visible 
through the cuticle of 1st- 3rd stage larvae. As showed in figure (14), the expression begins 
from the musculature of  the larval head and ends in the musculature of the  tail segments. 
Larval Brain shows weak Octß2R expression. Weak expression could be observed in 
mushroom bodies. Few numbers of neurons could be detected in the other parts of the CNS. 
A group of neurons from both hemispheres send axonal projections across the midline in the 
brain  forming the inter-hemispheric bridge. 
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Figure 14: GAL4 expression pattern of Octß2R -GAL4 in the larval muscular system 
A, Whole L3 larvae showing GFP in muscular system. B, close-up view of muscles of a live larva showing 
lateral transverse muscles (ltm). C, schematic drawing illustrating lateral view of larval musculature; yellow 
coloured  muscles refer to lateral transverse muscles (ltm), D and E, schematic drawing illustrating lateral view 
of larval musculature; Pink coloured  muscles refer to ventral longitudinal muscles (vlm); red coloured muscles 
refer to lateral oblique muscles (lom); blue coloured muscles refer to segment border muscles (sbm); green 
coloured muscles refer to lateral longitudinal muscles (llm); faint green coloured muscles refer to ventral oblique 
muscles (vom). F-H, larval musculature conjugated to the cuticle  stained immunohistochemically using α GFP 
antibody mixed with Phalloidin; F, GFP expression pattern; G, larval musculature conjugated to the cuticle 
labelled with Phalloidin. H, overlay of GFP and  dsRed photos (schematic drawings are modified from  
http://flybase.org).  
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Figure 15: GFP immunoreactivity of Octß2R -GAL4 in the larval brain. 
A, Octß2R immnuoreactivity showed in a whole mount larval brain. B, close –up view on the thoracic 
neuromeres; arrow refers somata  located on the dosolateral traces, sending a neuron toward the midline; head 
arrow refers two the other somata that located on the ventrolateral traces; sending a neuron also toward the 
midline. 
 
Adults also show also strong Octß2R expression in the entire abdominal musculature (Fig. 16 
A,F,G). Compared to the abdominal musculature of the larva, the abdominal musculature of 
the adult fly shows less expression. Dorsally there is a single layer of short longitudinal 
muscles, varying in number between 15 and 25 per segment. With their anterior end these 
muscles insert in the middle of a tergite, with their posterior end at the antecostal ridge of the 
posteriorlly adjacent segment. Ventral longitudinal muscles are reduced to two fibres that 
span the entire length of the segment. Lateral transverse muscles form a dense array of 12-15 
thin, parallel fibres that insert at the tergites (dorsally) and sternites (ventrally), respectively. 
Leg muscles show Octß2R expression in coxa (intracoxal depressor and intracoxal levators of 
trochanter), in the trochanter (redactor muscle of femur), in femur (levators and depressors of 
tibia) muscles, especially at the end of femur near the site of articulation with the tibia and 
tibial region (levator and depressor muscles of tarsus) as shown in Figure (16 B,C,D). The 
depressor muscle of tarsus shows Octb2R expression only at its base, near the site of 
articulation with tarsi. 
Antennae show strong Octß2R expression in the 3rd antennal segment, which may be due to 
glial cells or olfactory receptor neurons. Salivary glands and head musculature of adults show 
strong Octß2R expression (Fig, 17).  
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Strong GFP could be seen in the female reproductive system, in both virgin and mated 
females, in the three sperm-storing organs, spermathecae and seminal receptacle (Fig 18).  
 
 
Figure 16: GFP expression pattern in musculature of Octß2R -GAL4/UAS::GFP  adult 
stage. 
A, lateral view of adult female. B-D, showing expression in leg muscles. B, fore leg, C, middle leg and D, is hind 
leg. E, showing the expression in the muscles of the head region. F, ventral view of abdominal region transverse 
muscles in each abdominal segment. G, dorsal view of abdominal region showing 12-15 short, thin, parallel  
longitudinal muscle fibers  in each abdominal segment.  
 
 
 
 
Figure 17: GFP expression pattern in musculature of Octß2R -GAL4/UAS::GFP  adult 
stage. 
A, showing the expression in the maxillary palp (arrow);head arrow refers to proboscis. B, showing the 
expression in antenna; a1, antennal segment 1; a2, antennal segment 2; a3, antennal segment3. C, showing the 
GFP expression in adult  salivery glands.  
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Strong Octß2R was seen, in the male reproductive system (Fig. 19), in the male accessory 
gland .The secretions of the male accessory gland are very important for fertility, it also affect 
female egg production, oviposition, and possibly sperm storage. 
 
 
Figure 18: GFP expression pattern in Octß2R -GAL4/UAS::GFP  female reproductive 
system. 
A, schematic drawing  illustrating female reproductive system. B, female reproductive system; arrow referring to 
sperm storing organs (schematic drawing is modified from  http://flybase.org).  
 
 
 
Figure 19: GFP expression pattern in Octß2R -GAL4/UAS::GFP male reproductive 
system. 
 
 
In the adult brain, mushroom bodies have strong Octß2R signals (Fig 20). Two large clusters 
of varicose ramifications could be seen in the contralateral superior protocerebrum. Many 
groups of neurons could be distinguished, the first group of transverse neurons crosses the 
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midline dorsal to the fan shaped body and innervates the protocerebral bridge. Two large 
somata appear on the midline above the protocerebrum bridge, they send an axons along the 
midline. From the ventrolateral oesophagus, a thick axon runs laterally into the ipsilateral 
half, projecting into the cervical connectives. The second group of neurons, which project 
posteriorlly, some with twisted processes, bilaterally innervates the optic lobes. A 
conspicuously thick neuron projects from the anterior superior median protocerebrum, passes  
the posterior margin of the antennal lobe and ends ipsilaterally in the suboesophageal ganglia. 
A pair of somata, one on each side, could be seen in the ipsilateral inferior lateral 
protocerebrum where it sends a neuron to the ventrolateral protocerebrum. 
 
 
Figure 20: GFP  immunoreactivity in CNS of  Octß2R -GAL4/UAS::GFP  adults showen 
in projection of confocal  stacks (A-D). 
A,whole CNS. B, Octß2R immunoreactivity in adult brain; (C), mushroom bodies calyces; Arrows refer to pair 
of somata could be seen in the ipsilateral inferior lateral protocerebrum where each  send a projection to 
ventrolateral protocerebrum. C, Octß2R exists  in the thoracico abdominal ganglion; pro, prothoracic neuromere; 
meso, mesothoracic neuromere; meta, metathoracic neuromere; ag, abdominal ganglion. D, Octß2R 
immunoreactivity in adult brain; P, pedunculi; arrows refer to a pair of Octß2R neurons  pass  the posterior 
margin of the antennal lobe and end ipsilaterally in the suboesophageal  ganglion. 
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3.1.1.3. Octß3R expression analysis 
In Drosophila, the gene octß3R is referred by the symbol Dmel\Octß3R (CG42244). To 
isolate the putative promotor region (~3100bp), corresponding oligonucleotides were used. 
The promotor region was double digested with NotI and EcoRI restriction enzymes and 
directly inserted into the pPTGAL vector, which was prepared accordingly. This vector was 
used for germline transformation of w1118 flies. Studying the expression pattern was 
performed using the UAS /GAL4 binary system. The Octß3R-Gal4 lines were crossed to 
UAS-GFP driver line. The GFP expression pattern in the first generation was analysed in 
details.    
 
Figure 21: Generating Octß3R promotor inserted pPTGAL vector 
A, schematic drawing illustrating the Octß3R gene model and its products. B, 1% agarose gel showing Octß3R 
promotor region amplified with PCR. C, a part of pPTGAL vector with GAL4 coding sequence between 
minimum promotor (hsp70) and terminal transcription sequence (hsp70 terminator). pPTGAL vector was 
prepared for ligation by double digestion with NotI and EcoRI. D, schematic drawing for promotor-GAL4 - 
vector. The NotI/EcoRI double digested promotor sequence was inserted in the NotI/EcoRI double digested 
pPTGAL4 vector. 
 
The larval stage generally shows weak Octb3R expression. Scattered sensilla which are 
aligned at more or less regular intervals can be found in each hemisegment (Fig.22A,B). 
These sensilla are composed of three types; hairs or bristles (sensilla trichoidea, sensilla 
chaetica), pegs (sensilla basiconica, sensilla coeloconica), and pits or papillae (‘‘papilla 
sensilla,’’ in some cases classified as sensilla campaniformia). 
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Figure 22: GFP expression pattern in of the Octß3R -GAL4/UAS::GFP third larval stage  
A, the whole mount third stage larva. B, close view of the posterior part of the larval body showing the scattered 
distribution of the sensilla.    
 
 
The thoracic sensilla in Drosophila larvae may represent mixed hygro-/temperature receptors, 
based on the ultrastructural resemblance of these organs with sensilla of other insects 
(classified as styloconical or basiconical sensilla), which have been investigated electro- 
physiologically (Altner et al., 1981; Hartenstein, 1988). Moderate Octb3R expression can be 
observed in the larval CNS (Fig.23A,B). The strongest expression could be found in 
mushroom bodies. GFP-positive somata are located on the dorsolateral traces and along the 
midline in the thoracic and abdominal neuromere. 
 
 
Figure 23: GFP immunoreactivity in the CNS of the Octß3R -GAL4/UAS::GFP larval 
stage. 
A, schematic drawing illustrating the GFP expression pattern in the larval brain; somata could be seen on the 
dorsal surface of each hemisphere especially those conjugated to the α/α´ lobes of mushroom body. Somata 
could also be seen in the thoracico-abdominal ganglion along the midline and along the dorsolateral trace. B, 
maximum intensity projection of confocal stacks of GFP expression of larval CNS. Strong GFP could be seen in 
mushroom body. 
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Figure 24: GFP immunoreactivity in the Octß3R -GAL4/UAS::GFP adult CNS. 
A-L, optical sections showing the innervation of the central brain by octß3R. A, arrows refer to two  dorsal 
unpaired median somata. B and C,  arrow refers to a cluster of somata located in the mechanosensory center; 
sending projections passing the antennal lobes toward middle region. D, spiny arborizations surrounding the 
esophagus foramen (oes); cx, calyx of mushroom body. E and F, innervation of the protocerebrum; arrow refers 
to a neurite extended in the lateral posterior protocerebrum. G, arrow refers to the position of the ventral 
unpaired median soma; head arrows refer to two pairs of somata, one pair each side, located in the 
mechanosensory center. H, head arrow refers to cluster of somata located in the posterior region  of the sog send  
projections toward the midline. I, octß3R expression in the mushroom body substructures and ellipsoid body. J 
and K, a lot of somata  could be seen in the subesophageal  and the antennal ad mechanosensory center. Most of 
them sent projections toward the mid line. L, a thick neuron projected from the dorsal unpaired median soma 
bifurcate near the mid line, each branch extend to the antennal lobe, rolling inside and ascend out of the antennal 
lobe toward the median protocerebrum.  
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Figure 25: GFP immunoreactivity in the Octß3R -GAL4/UAS::GFP adult brain. 
A, schematic drawing illustrating Drosophila brain centres. B, projection of confocal stacks illustrating the bulky 
expression of octß3R in the antennal lobes , mechanosensory center and subesophageal ganglia. Arrow refers to 
the  neuron that roll up inside the antennal lobe and ascend to the median protocerebrum.  Head arrow refers to 
somata that could be seen in the antennal lobe. MB, mushroom body; p, pedunculus; ant lob, antennal lobe; ant 
n, antennal nerve; Sog, subesophageal ganglion; m bdI, median bundle; smpr superior median protocerebrum; v 
bo, ventral body (schematic drawing is modified from http://web.neurobio.arizona.edu/Flybrain) . 
 
 
In the adult brain, bulky expression of octß3R could be seen in the antennal lobes, 
mechanosensory center and subesophageal ganglion (fig.24,25). Distinct Octb3R expression 
was seen in the mushroom bodies and the ellipsoid body. Two dorsal unpaired median somata 
could be seen posteriorlly along the midline. A thick neuron projected from the dorsal 
unpaired median soma bifurcate near the mid line, each branch extends to the antennal lobe, 
rolling inside and ascends out of the antennal lobe toward the median protocerebrum. A 
cluster of somata located in the mechanosensory center; sending projections passing the 
antennal lobes toward middle region. Spiny arborizations surrounding the esophagus foramen 
(oes). Positively expressed cluster of somata located in the posterior region of the sog send 
projections toward the midline. 
  
3.1.1.4. Oa2 expression analysis 
In Drosophila, the gene octopamine receptor2 is referred by the symbol Dmel\oa2 (CG6919). 
The putative promotor region was amplified by PCR (~1500bp). The amplificate was inserted 
into the pJET vector (MBI Fermentas). The pJET vector was then prepared by double 
digestion with NotI/BamHI and the insert transferred to pPTGAL, which was prepared 
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accordingly. The oa2-Gal4 line, in which the expression of oa2 drives Gal4 was crossed to 
UAS-GFP Driver line. GFP expression in the first generation was analyzed in details.  
 
 
Figure 26: Generating oa2 promotor inserted pPTGAL vector. 
A, schematic drawing illustrating the oa2 gene model and its products. B, 1% agarose gel showing oa2 promotor 
region amplified with PCR. C, a part of pPTGAL vector with GAL4 coding sequence between minimum 
promotor (hsp70 TATA) and terminal transcription sequence (hsp70 terminaltor). pPTGAL vector was prepared 
for ligation by double digestion with NotI and BamHI. D, schematic drawing for promotor-GAL4 -vector. The 
NotI/BamHI double digested oa2 promotor sequence was inserted in the NotI/BamHI double digested pPTGAL4 
vector. 
                                                                                   
 
Figure 27: GFP expression pattern in the oa2-GAL4/UAS::GFP in the larval stage. 
A, the whole third stage larva; arrow refers to the GFP expression pattern in the main branches of trachea. B, 
GFP expression pattern in dissected tracheal system. C, GFP expression pattern in midgut cells; nuclei (blue) 
were stained by Hoechst staining. D, GFP expression pattern in the malpighian tubule;  nuclei were stained by 
Hoechst staining. 
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In the larval stage very strong oa2 expression could be seen (Fig. 27), especially in the main 
branches of the tracheal system, which are visible through the cuticle of living larvae. Strong 
GFP expression could be seen in the midgut cells and in the malpighian tubules. 
Very strong expression could be seen in the larval CNS (Fig.28). Scattered somata located on 
the dorsal surface of each hemisphere express the oa2 receptor gene. The somata of the 
thoracic oa2 neurons reside ventro-medially in the cortex beneath the centro-intermediate 
trace. The abdominal ganglia contain three morphological different oa2 expressing groups of 
neurons. The first group of oa2 neurons consists of bilateral pairs of dorso-lateral neurons 
with three somata, composing a cluster and residing at the height of the dorso-lateral traces in 
each neuromere from abdominal ganglion 1 to 8.  The second group of oa2 expressing 
neurons is located bilaterally in each abdominal neuromere. Typically, a pair of oa2 
expressing neurons resides in each of the abdominal neuromers, except for the last two 
ganglia. The somata of these abdominal oa2 expressing neurons are ventro-laterally on the 
ventro-lateral trace. The third group comprises ventral paired median oa2 neurons, their 
somata are located in the cortex beneath the ventro-median tracts. Outside of the ventral 
ganglion, these pair of neurons join and project together via the segmental nerves to the 
periphery. 
Strong GFP expression could be seen in the larval eye anlage, which are stem cell-like 
progenitors (neuroblasts) of the protocerebrum. The eye anlage remains part of the surface 
epithelium until later in embryogenesis, give rise to adult eye and inner and outer optic lobes.  
In the adult stage, strong GFP expression could be seen in the wing veins (Fig. 29). The 
venation pattern consists of five longitudinal veins and cross veins which are thick cuticular 
regions providing structural support and nervous /heamolymph conduits.  
Strong oa2 expression could be seen in adult CNS (Fig. 30). A pair of  cluster of somata, one 
each side, located at the pars intercerebralis which are the major insulin producing cells in the 
fly (Rulifson et al., 2002). Some of their projections project laterally along with the median 
bundle, these right and left projections cross each other, forming a chiasma and continue 
projecting till the ventromedial part at the base of antennal lobes. Other neurons, from those 
which are projecting along the median bundle, project laterally and pass the antennal lobe 
toward the optic lobes where they extend in strongly labelled ramifications. Mushroom bodies 
moderately express oa2. Scattered and strongly labelled somata are located laterally in the 
subesophageal ganglion (sog). Strongly labelled somata surrounded the antennal lobes could 
be seen. Many somata are scattered around the protocerebral bridge and the core of α and β 
lobes of mushroom bodies. 
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Figure 28: GFP immunoreactivity in the CNS of the oa2-GAL4/UAS::GFP larvae. 
A, schematic drawing illustrating the oa2 expression in the larval CNS. B, maximal intensity projection of 
confocal stacks. C, average intensity projection of confocal stacks; arrows refer to somata in thoracic 
neuromeres; head arrows refer to somata clusters located on the dorso-lateral traces in each abdominal 
neuromere. D, projection of confocal stacks; arrows refer to somata which are located on the dorsal surface of 
each hemisphere. E, close view of the last six abdominal neuromeres; black arrows refer to somata locate in the 
cortex beneath the ventro-median tracts, their projecting  neurons join and project  together via the segmental 
nerves to the periphery. F, close view of the abdominal neuromeres; arrow refer to the lateral clusters of somata 
located on the dosolateral trace in each neuromere. G, confocal image of GFP expression in larval eye anlage; el, 
eye anlage.  
 
 
 
Figure 29: GFP expression pattern in the wing venation of the oa2-GAL4/UAS::GFP 
adults. 
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Figure 30: GFP immunoreactivity in the CNS of oa2-GAL4/UAS::GFP adults. 
A, schematic drawing illustrating the oa2expression in the adult brain; MB, mushroom body; lo, lobula; me, 
medulla; ant lo, antennal lobe; sog, suboesophageal ganglion. B, maximal intensity projection of confocal stacks 
illustrating the oa2 expression pattern in the whole CNS. C, average intensity projection of confocal stacks 
illustrating the oa2 expression pattern in the whole CNS. D, close view on the brain. E, close up view of the 
brain; arrow refer to the moderately expressed mushroom body; head arrow refer to projections run laterally 
along with the median bundle, these right and left projections cross each other forming chiasma and continue 
projecting till the ventromedial  region at the base of antennal lobes. F, close view on the optic lobe; the lobula 
(lo), lobula plate and medulla (me) are innervated by oa2 neurons; arrow refers to the main and strong expressed 
neuron. G, close view on the middle part of the brain; right arrow refers to cluster of somata located at the pars 
intercerebralis which are the major insulin producing cells in the fly (Rulifson et al., 2002); middle arrow refers 
to strong expressed great commissure connecting the brain hemispheres; isosceles arrow refers to neuron 
projecting along the median bundle, project laterally and pass the antennal lobe toward the optic lobes where 
they extend in strongly labelled ramifications. H, strong labelled intercalating ramifications of the great 
commissure and the neurons that innervate the optic lobe; arrow refers to those intercalating ramifications. I, 
GFP expression pattern in the thoracic-abdominal ganglion; pro, prothoracic ganglion; meso, mesothoracic 
ganglion; meta, metathoracic ganglion; ag, abdominal ganglion. Scale bar = 50µm.  
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Figure 31: GFP immunoreactivity in the central complex in the brain of the oa2-
GAL4/UAS::GFP adults. 
A, schematic drawing illustrating the central complex and suboesophageal ganglion;  eb, ellipsoid body; vb, 
ventral body; no, noduli; spsl, superior posterior slope surrounding the esophagus (oes); ipsl, inf erior posterior 
slope  surrounding the esophagus. B, confocal image showing close view of central complex; fine OA2 positive 
ramifications could be confined in the posterior region of ellipsoid and noduli (no). Dense ramifications spread 
in the superior (spsl) and inferior posterior slope surrounding the esophagus foramen 
 (schematic drawing is modified from http://web.neurobio.arizona.edu/Flybrain/html/atlas/index.html). 
 
 
A great commissure could be seen connecting the adult brain hemispheres, sending strong 
labelled ramification toward the optic lobe. The lobula, lobula plate and medulla in the optic 
lobe are innervated by oa2 neurons. In Drosophila, central complex located at the 
interhemispheric junction, consists of four structures; protocerebral bridge, fan-shaped body, 
ellipsoid body and pair of noduli. Relatively weak expression was confined in central 
complex (Fig.31), however, some ramifications innervated the ellipsoid and paired noduli 
could be seen.  
 
3.1.2. Dopamine receptors 
3.1.2.1. DopR expression analysis 
In Drosophila, the gene Dopamine receptor is referred by the symbol Dmel\DopR (CG9652). 
To amplify the DopR promotor region (~800bp) corresponding sense and antisense 
oligonucleotides were used. The DNA containing the promotor region was inserted into the 
pJET vector (MBI Fermentas) via directional cloning using NotI and BamHI restriction sites. 
Following verification of correct integration by sequencing, the insert was transferred into the 
pPTGAL vector, which was used for production of transgenic lines by germline integration 
(injection service BestGene). Studying the expression pattern was performed using the UAS 
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/GAL4 system (Brand and Perrimon, 1993a). The DopR-Gal4 line was crossed to a UAS-GFP 
responder line, thus allowing to visualize expression of the DopR gene by GFP expression. 
 
 
Figure 32: Generating DopR promotor inserted pPTGAL vector. 
A, schematic drawing illustrating the DopR gene model and its products. B, 1% agarose gel showing DopR 
promotor region amplified with PCR. C, a part of the pPTGAL vector with the GAL4 coding sequence between 
a minimum promotor (hsp70) and termination sequence (hsp70 terminaltor). The pPTGAL vector was prepared 
for ligation by double digestion with NotI and BamHI. D, schematic drawing of the vector construct. The 
NotI/BamHI double digested DopR promotor sequence was inserted into the NotI/BamHI double digested 
pPTGAL vector. 
 
 
The DopR expression pattern was analyzed in detail in the larval and adult progeny from this 
cross. Strong GFP expression could be seen in the larval salivary gland, which was even 
visible through the cuticle. Distinct expression was also found in the larval fat body. Strong 
GFP was seen in the larval gut (Fig.33). To identify the cells within the gut that express the 
DopR, I performed immunohistochemical studies with three different primary antisera; anti-
GFP, anti-prospero and anti-armadillo to label specific intestinal cells. Interspread among the 
monolayer of intestinal cells are enteroendocrine cells, which express different peptides. Most 
of enteroendocrine cells express the transcription factor prospero and also the ß-catenin 
homologue Armadillo. Most of the Armadillo- positive cells show strong DopR 
immunoreactivity.    
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Figure 33: GFP expression pattern in the DopR-GAL4/UAS::GFP larval stage. 
A, GFP expression pattern in the gut. B, the same gut is co-labelled with α armadillo antibodies (DsRed 
channel). C, overlay of DsRed and GFP; nuclei are stained with DAPI (blue). D, close view of the gut showing 
the GFP expression pattern. E, GFP expression pattern in the larval fat body; nuclei are stained with DAPI 
(blue).  
 
 
GFP expression pattern of the DopR in larval brain appear as connected bundles in the brain 
cortex because secondary small axon traces travel radially connecting the DopR positive 
somata within the hemisphere (Fig.34). These DopR expressing somata are located on almost 
all neuropile secondary traces including; medial dorsoposterior, lateral dorsoanterior, medial 
dorsoanterior, lateral dorsoposterior traces which are located dorsally in each hemisphere; 
centromedial and centroposterior which are located in the centre of the neuropile; basolateral 
anterior, basolateral ventral and basolateral posterior traces in the base of each brain 
hemisphere. Strongly expressed somata are also located in the thoracico-abdominal ganglion. 
The outline detecting optic lobe also expressed DopR. Strongly expressing somata are also 
located dorsally on the optic lobe. Two large and strong expressed somata also located on the 
medial dorsoposterior in the hemisphere. Some of the strongly expressed neurons project 
from the neuropile toward the optic lobe. 
In the adult stage strong GFP expression could be seen in the thoracic region, which is due to 
strongly expressing flight muscles (fig. 35). 
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Figure 34: GFP immnuoreactivity in the CNS of the DopR-GAL4/UAS::GFP larval 
stage. 
A, projection of confocal stacks illustrating the GFP expression pattern in the CNS of 3rd instar larva. The GFP 
was seen in the surface of the brain hemisphere and cortex and neuropile regions; OL, optic lobe; Th abd, 
thoracico-abdominal ganglion. B and C, 3D models of brain hemisphere (B, dorsal view ; C, anterior view) 
showing hemisphere regions located by colored spheres; the outline of the optic lobe is indicated by gray line; 
mushroom body indicated by shaded dark gray; (DPM), medial dorsoposterior; (DPL), lateral dorsoposterior; 
(DAM), medial dorsoposterior; (DAL), lateral dorsoanterior;(DPL), lateral dorsoposterior; (DPM), medial 
dorsoposterior; (BLA), basolateral anterior;(BLD), basolateral dorsal;( BLP), basolateral posterior; (BLV), 
basolateral ventral; (CM), centromedial (Pereanu and Hartstein; 2006). D, projection of confocal stacks showing 
close view on the larval brain hemispheres. Strong expressed somata located in central neuropile; arrow refer to 
the GFP in outline of the optic lobe; head arrow refer to group of somata located dorsally on the optic lobe. E-G, 
confocal stacks. E, arrow refer to pair of large and strong expressed somata located medial dorsoposterior, one 
each hemisphere. F, arrow refers axons projected in the centroposterior (CP) and centromedial in the neuropile. 
G, arrow refers to a projection from a soma located in the neuropile toward the optic lobe. H, close view on one 
brain hemisphere; arrows refer to several axons located in the central neuropile; head arrow refer to somata 
located in the medial drosoposterior (DPM) in the cortex. Scale bar = 150µm. 
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Figure 35: GFP expression pattern in the whole DopR-GAL4/UAS::GFP adults. 
Arrow refers to the GFP in flight muscles. 
 
In the adult brain, the DopR positive somata and axons could be seen almost everywhere in 
the supra- and subesophageal ganglia as well as in the optic lobes (Fig. 36 and 37). Mushroom 
body substructures strongly express DopR. Within the interhemispheric junction, strong GFP 
expression could be seen in the central complex substructures including; the outer margin of 
the fan-shaped body; some positive DopR neurons including somata which innervate the 
ellipsoid body; noduli and some axonal projections connecting the central complex 
substructures. Dense ramifications spread in the superior and inferior posterior slope 
surrounding the esophagus foramen. Strong GFP expression was seen in the optic lobe 
including lobula, lobula plate and inner- and outer medulla.  
Two large somata could be seen in the ventro-medial part of the subesophageal ganglion. 
DopR positive neurons project from posterior inferior lateral protocerebrum into the 
ventromedial protocerebrum. In addition, DopR positive neurons project from posterior 
inferior lateral protocerebrum towards the midline. Strongly expressing somata are also 
located in the lateral protocerebrum and in the ventrolateral part of the antennal lobe and 
antennal nerve. A cluster of strongly expressed somata is located in the ventrolateral 
protocerebrum. Positive DopR neurons ramified bilaterally into the ventromedial 
protocerebrum, they have their somata located on the midline of the subesophageal ganglion 
with mirror symmetry. They can be divided into three neuromeres (mandibular, maxillary, 
and labial) in the gnathal segment. Therefore, these subclusters are named VMmd, VMmx 
and VMlb from anterior to posterior. The GFP expression is strong in both VMmx and VMlb 
but it is moderate in the VMmd cluster. The secondary neurons turn ventrally to descend 
through the cervical connective. These descending axons terminate in all three thoracic 
ganglia and abdominal ganglia (Fig.37). 
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Figure 36: GFP immnuoreactivity in the DopR-GAL4/UAS::GFP adult brain. 
A, maximal intensity projection of confocal stacks which was collected at 1.5µm steps; arrow refers to GFP 
expression the medulla region of the optic lobe; head arrow refers to two large somata that could be seen in the 
ventro-medial of the subesophageal ganglion. B, maximal intensity projection of confocal stacks which was 
collected at 1µm steps; arrow refers to the strong GFP expression in the mushroom body; head arrow refers to 
the strong expressed somata located  on the ventromedial of the antennal lobes. C-F, confocal sections of the 
brain. C, arrow refers to DopR positive neuron projecting from posterior inferior lateral protocerebrum into the 
ventromedial protocerebrum; D, arrow refers to DopR positive neuron projects from posterior inferior lateral 
protocerebrum toward the midline. E, arrow refers to strong expressed somata located in the lateral 
protocerebrum; short arrow refers to somata located in the ventrolateral of the antennal lobe and antennal nerve. 
F, head arrow refers to a cluster of strong expressed somata located in the ventrolateral protocerebrum. G-J, 
single optical sections of distinct brain regions. G, single optical section illustrating close view of the anterior 
protocerebrum. H, close view on subesophageal ganglion; al, antennal lobe; VMmd, VMmx and VMlb refer to 
the three somata subclusters along the midline of the subesophageal ganglion which represent three neuromeres ( 
mandibular, maxillary and labial). These somata send a projection toward the supra oesophageal ganglion; 
dashed line indicates the midline of the subesophageal ganglion.  Scale bar = 150 . 
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Figure 37: GFP immnuoreactivity in the thoracico abdominal ganglion  of the DopR-
GAL4/UAS::GFP adult stage. 
A, GFP expression pattern in the whole thoracico abdominal ganglion. B, oblique view from the anterior so as 
better to visualized the beginning (pro- and meso- thoracic ganglia) of the thoracico abdominal ganglion. The 
thoracico abdominal ganglion is tilted about 45° to the right; the dashed line indicates the midline of the 
thoracico abdominal ganglion; pro, prothoracic ganglion; meso, mesothoracic ganglion. C, oblique view from the 
posterior so as better to visualized the bottom (metathoracic ganglion and abdominal ganglion) of the thoracico 
abdominal ganglion. The thoracico abdominal ganglion is tilted about 45° to the right; the dashed line indicates 
the midline of the thoracico abdominal ganglion.  
 
 
3.1.2.2. DopR2 expression analysis 
In Drosophila, the gene Dopamine receptor2 is referred by the symbol Dmel\DopR2 
(CG18741). As described for the other receptor genes, the DopR2 promotor region (~ 3000 
bp) was amplified by PCR. This amplificate was directly inserted into the pPTGAL vector 
(fig.38) via NotI and BamHI restriction sites. This vector was used for making transgenic 
lines via germline integration into w1118 flies (BestGene). Studying the expression pattern was 
performed using the UAS/GAL4 binary system. The DopR2-Gal4 lines were crossed to UAS-
GFP responder line and larval and adult stage of the first generation were analyzed in detail. 
Strong GFP expression could be seen in the larval gut cells (Fig. 39A). The tracheal system of 
larvae shows strong GFP expression, which could be seen through the cuticle (Fig. 39 B). It is 
present in the three major parts of the tracheal system; the primary airways, the secondary 
airways, and the blind ending terminal ones. Terminal branches strongly express GFP. They 
are very thin extensions contacting almost every single cell.  
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Figure 38: Generating DopR2 promotor insertion pPTGAL vector. 
A, schematic drawing illustrating  DopR2 gene model and its products. B, 1% agarose gel showing DopR2 
promotor region amplified with PCR. C, a part of pPTGAL vector with GAL4 coding sequence between 
minimum promotor (hsp70) and termination  sequence (hsp70 terminator). pPTGAL vector was prepared for 
ligation by double digestion with NotI and BamHI. D, schematic drawing of the promotor-GAL4-vector. The 
NotI/BamHI double digested DopR2 promotor sequence was inserted into the NotI/BamHI double digested 
pPTGAL vector. 
            
 
 
Figure 39: GFP expression pattern in distinct tissues of the DopR2-GAL4/UAS::GFP 
larvae. 
A, GFP expression pattern in the larval gut; arrow refers to GFP expressed intestinal cells. B, GFP expression 
pattern in the larval tracheal system. 
 
 
Distinct DopR2 expression was detected in the larval CNS (Fig. 40). Huge numbers of somata 
could be detected in the medial dorsoposterior and lateral dorsoposterior in each brain 
hemisphere with non-mirror symmetry. These short axons including somata form a dense 
meshwork structure. From these somata, a moderately labelled projection travel to the optic 
lobe. DopR2 positive somata, axons and ramifications could be seen in the centromedial and 
basolateral ventral part of the brain hemisphere. They are conjugated with final branches of 
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the tracheal system. In the thoracico abdominal ganglia, each thoracic neuromere contains two 
pairs of DopR2 transverse neurons. These neurons are located laterally.  
The ventral ganglion contains two morphologically different DopR2 transverse neuronal 
groups: the first DopR2 containing neuronal group consists of a pair of dorso-lateral neurons 
with somata residing at the height  of the dorso-lateral tracts in each neuromere from the 1st to 
the 7th  abdominal ganglia which are parallel with very fine branches of the tracheal system. 
In each abdominal ganglion, neurons from both sides join in one plexus beneath the centro-
intermediate tracts and  project together  via the segmental nerves to the periphery. 
These somata which are located on the dorsolateral trace, project  into at least 4 regions.  Each 
DopR2 neuron in the thoracic and abdominal ganglia sends a neurite beneath the transverse 
projection. These neurites from both sides join in proximity to the ventro-median tracts. These 
joining DopR2 containing neurites form extensive arborisations along the midline between the 
dorso-median and ventro-median tracts.  
In the adult stage, terminal branches of the tracheal strongly express GFP. They are very thin 
extensions contacting in many tissues almost every single cell. As shown in (fig.41) the fine 
branches of trachea supply legs and visceral branches supply the gut. 
The adult CNS showed strong DopR2 expression (Fig. 42). Mushroom body substructures are 
strongly labelled with GFP. Thick and strong expressing ramifications and projections spread 
all over the protocerebrum, especially in the anterior superior medial protocerebrum, with 
their somata located in the ventrolateral protocerebrum (vlpr). A cluster of somata located in 
the anterior superior medial protocerebrum sends three groups of  projections; those extending 
to the ventrolateral region of the protocerebrum;  projections extending laterally to innervate  
the optic lobes; and the third group of these projections ascend along the midline innervating 
the central complex substructures and the interhemispheric junction. GFP expressing somata 
located in the superior and inferior posterior slope in the suboesophageal ganglion (sog). Two 
DopR2 positive neurons are located in the anterior superior protocerebrum with axon 
projecting laterally to the optic lobe.  Strong GFP expression could be seen in the lobula (Lo) 
as well as the inner and outer medulla (me) in the optic lobe. 
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Figure 40: GFP immnuoreactivity in the CNS of DopR2-GAL4/UAS::GFP larvae. 
A,B and D, projection of confocal stacks illustrating the DopR2 expression. A, GFP expression pattern in the 
whole mount larval CNS. B, projection of confocal sections of one brain hemisphere; DopR2 expressed by the 
surface of the brain hemisphere; short axons including somata were seen in the medial dorsoposterior and lateral 
dorsoposterior regions of the brain hemisphere which form dense meshwork. C, 3D models of the dorsal view of 
brain hemisphere showing hemisphere regions located by colored spheres; the outline of the optic lobe is 
indicated by gray line; mushroom body indicated by shaded dark gray; (OL), optic lobe. (DPM), medial 
dorsoposterior; (DPL), lateral dorsoposterior;( DAM), medial dorsoposterior; (DAL), lateral dorsoanterior; 
(BLA), basolateral anterior;(BLD), basolateral dorsal;( BLP), basolateral posterior; (BLV), basolateral ventral; 
(CM), centromedial (Pereanu and Hartenstein; 2006). D, close view of the DopR2 neurons laterally located in 
the thoracicoabdominal neurons with their projections to the medial traces.  E, schematic drawing of  the GFP 
expression pattern in the thoracico abdominal ganglia; the main traces in the thoracico abdominal ganglia are the 
dorsolateral trace, the centro-intermediate trace and the dorsomedial trace; (t1-t3) first, second and third thoracic 
neuromeres.; (a1-a8) the  first to the eight abdominal ganglia. Scale bar = 150µm. 
 
 
 
Figure 41: GFP expression pattern in the fine terminal branches of the tracheal system 
in the DopR2-GAL4/UAS::GFP adult stage. 
A and B, arrows refer to the tracheal branches supplying the legs of adult stage. C, arrow refers to the fine 
visceral branches of the tracheal system supplying the gut.  
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Figure 42: GFP immunoreactivity in the DopR2-GAL4/UAS::GFP adult brain. 
A, projection of confocal stacks illustrating the GFP expression pattern in the adult brain; long arrow refer to 
GFP labels thick and strong expressed ramifications and projections spread all over the protocerebrum with their 
somata located in the ventrolateral protocerebrum (vlpr); short arrow refer to a pair of somata located in the 
anterior superior medial protocerebrum sending projections to the ventrolateral region of the protocerebrum and 
to the optic lobes; empty head arrow refers to GFP expressed somata located in the superior and inferior 
posterior slope in the suboesophageal ganglion (sog). B1-B4, single optical sections of the ipsilateral optic lobe 
illustrating ramifies, showed by arrows with the same position and angle in the four  sections,  in the lobula (Lo); 
the inner and outer medulla (me). B4, head arrow  refers to a single axon project laterally to the optic lobe. C1-
C3, confocal sections of the central brain; C1, arrow refers to DopR2 positive neurons located in the anterior 
protocerebrum with an axon projects laterally to the optic lobe; C2, arrow refers to strong expressed somata 
located in the lobula of the optic lobe; C3, arrow refers to an axon located in the superior protocerebrum project 
laterally to optic lobe. D, a single confocal section illustrating GFP expression in the mushroom body (MB). E-
G, single optical sections of distinct brain regions. E, magnifications of the protocerebrum; which contains 
ramifies surrounding the central complex substructures referred by long arrow; pro1 refers to an axon project 
laterally to the optic lobe; the short arrow refers to this axon within the optic lobe; p, pedunculus. F, arrows 
refers to axons pass the midline of the protocerebrum. G, pro1 and pro2 refer to axons innervating the optic 
lobes. 
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3.1.2.3. D2R expression analysis 
In Drosophila, the gene Dopamine 2-like receptor is referred by the symbol Dmel\D2R 
(CG33517). The D2R promotor region was amplified by PCR (~ 3500 bp). This PCR product 
was double digested with NotI/BgIII restriction enzymes and directly inserted into the 
pPTGAL vector (fig.43), which was used for germline transformation. As already described, 
the expression pattern was studied using the Gal4/UAS-system via crossing the corresponding 
lines with UAS-gfp. 
 In the larval stage very strong D2R expression is seen in the tracheal system, which is visible 
through the cuticle of living larvae (fig 44). In addition, fine tracheal branches which contact 
the viscera are also GFP-positive. Strong GFP was also seen in the salivary glands. In the 
digestive system, strong expression was found in the foregut, atrium, pharynx and 
oesophagus. Within the pharynx, pharyngeal muscles are peculiarly positive. No expression 
was seen in the rest of the foregut. Strongly expressing muscles stripes could be seen in the 
hindgut.   
 
Figure 43: Generating D2R promotor inserted pPTGAL4 vector 
A, schematic drawing illustrating the D2R gene model and its products. B, 1% agarose gel showing D2R 
promotor region amplified with PCR. C, a part of pPTGAL vector with the GAL4 coding sequence between a 
minimum promotor (hsp70) and terminal transcription sequence (hsp70 terminaltor). pPTGAL vector was 
prepared for ligation by double digestion with NotI and BgIII. D, schematic drawing of the promotor-GAL4 -
vector. The NotI/BgIII double digested D2R promotor sequence was inserted in the NotI/BgIII double digested 
pPTGAL vector. 
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Figure 44: GFP expression pattern in the D2R -GAL4/UAS::GFP larval stage 
A, the whole third stage larvae; arrow refers to GFP labeling the tracheal system. B, GFP expression pattern in 
the larval salivary gland. C, GFP expression pattern in the tracheal system. D, GFP labels the fine visceral 
branches of trachea supplying the gut. E, GFP labels the anterior region of the foregut  including  the atrium, 
pharynx and oesophagus. F, magnification of the pharyngeal region; arrow refers to the pharyngeal muscles. G, 
mid- and hindgut region; long arrow refers to two muscle strips along the hindgut.   
 
 
In the larval CNS, strong GFP was seen in CNS (Fig. 45). Moderate GFP was seen in 
mushroom body substructures including: b/b´ lobes, GFP expression pattern in the α/α´ lobes 
appears as a cap over the lobes and GFP expression appears as a cap over the calyx of 
mushroom body. Somata and projections could be seen allover the brain hemisphere. Strongly 
expressing somata could be seen in the thoracicoabdominal ganglia along the midline, they 
send transverse projections toward the dorsolateral trace and some of their projections come 
out of the brain to the periphery. 
Large and strong D2R expressing somata were seen in the dorsoanterior neuropile region and 
dorsoanterior surface of the brain hemispheres. They send axons toward the interhemispheric 
junctions. Most of these axons come out of the brain. 
Strong GFP expression could be seen in the larval eye anlage, which are stemcell-like 
progenitors (neuroblasts) of the protocerebrum. They delaminate from the ectoderm and form 
a proliferating cell layer. The eye anlage remains part of the surface epithelium until later in 
embryogenesis, giving rise to adult eye and inner and outer optic lobes.  
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Figure 45: GFP immunoreactivity in the CNS of the D2R -GAL4/UAS::GFP larval 
stage. 
A, maximum intensity projection of confocal stacks illustrating the GFP expression pattern in larval CNS. B-F, 
close ups of different optical sections.B, GFP expression pattern in eye anlage; arrow refers to eye anlage which 
appear as a stem-like projection of the protocerebrum. C, close up view of one brain hemisphere; arrows refer to 
somata which are distributed everywhere in all hemisphere regions. D,  close up view of the brain hemispheres 
and interhemispheric junction; short down arrow refers to GFP expression pattern in the α/α´ lobes of mushroom 
body which appear as a cap over the lobes; long down arrow refers to the GFP expression in the calyx of 
mushroom body which appear as a cap over the calyx; left arrow refers to the GFP expression along the midline 
of the interhemispheric junction. E, close up view on the somata and neurons in the thoracic neuromeres; black 
arrows refer to D2R expressed somata. F, close up view on the GFP expression pattern in the 
thoracicoabdominal ganglia; arrow refers to strong expressed and large in size somata which are located along 
the midline in each abdominal neuromere. Each somata send a projection ipsilaterally toward the dorsolateral 
trace. 
 
 
In adult CNS, Mushroom body substructures could not be distinguished, but some positively 
stained projections adjacent to the mushroom body could be identified (Fig.47). Some of 
these projections extend medially toward the fan-shaped body of the central complex which 
may suggest that these projections serve as neural circuits linking the central complex with 
the mushroom body to facilitate the flow of informations. 
Receptor expressing somata conjugated with the pedunculi of the mushroom body send thick 
projections that extend toward the anterior superior protocerebrum, passing the antennal lobe. 
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This projection could not be seen after passing the antennal lobe which may suggest that it 
connects the mushroom body with the antenna and antennal nerve. 
Another structure displaying strong D2R expression was the central complex. The central 
complex located at the interhemispheric junction consists of four interconnected 
substructures, protocerebral bridge, fan-shaped body, ellipsoid body and pair of noduli. From 
the central complex very strong expressing neurons extend up along the brain midline, which 
may be the main central complex out put. Positive expressing projections adjacent to noduli 
extend laterally in each hemisphere toward the optic lobes and their arborisations extend 
around the esophagus foramen. D2R positive cell clusters were found in the entire lateral 
protocerebrum, posterior lateral protocerebrum, posterior inferior lateral protocerebrum and 
ventrolateral protocerebrum  forming dense meshwork connecting these regions. Cluster of 
somata located along the ventral midline of the subesophageal ganglia are also present.  
 
 
 
 
Figure 46: GFP immunoreactivity in the central complex substructures D2R -
GAL4/UAS::GFP adult brain. 
FB, Fan-shaped body. EB, ellipsoid body. No, paired noduli .  
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Figure 47: GFP immunoreactivity in the D2R -GAL4/UAS::GFP adult brain. 
A, Z-projection of confocal stacks (optical sections); CC, central body complex. Me, medulla and Lo, lobula of 
optic lobe; sog, subesophageal ganglia; short arrow refers to positive expressed somata conjugated with the 
pedunculi of the mushroom body which project into thick axon extend toward the antennal lobe; long arrow 
refers to cluster of somata located along the ventral midline of the subesophageal ganglia. B1-B9, optical 
sections of the central brain. 
 
 
3.1.3. Tyramine receptors  
3.1.3.1 TyrR expression analysis 
In Drosophila, the gene tyramine receptor is referred by the symbol Dmel\TyrR CG7485. To 
amplify the TyrR promotor region (~ 4000 bp), corresponding TyrR sense and anti-sense 
oligonucleotides were used. The DNA containing the promotor region was inserted into the 
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pPTGAL vector as described before, and  was used for the production of transgenic lines by 
germline integration (injection service BestGene Inc.). Studying the expression pattern was 
performed using the UAS/GAL4 system (Brand and Perrimon, 1993a). The TyrR-GAL4 line 
was crossed to a UAS-GFP responder line, thus allowing visualizing the expression of the 
TyrR gene by GFP expression.  
 
Figure 48: Generation of the TyrR promotor containing pPTGAL4 vector 
A, schematic drawing illustrating the TyrR gene and its products. B, 1% agarose gel showing TyrR promotor 
region amplified with PCR. C, a part of the pPTGAL vector with the GAL4 coding sequence between a 
minimum promotor (hsp70) and termination sequence (hsp70 terminator). The pPTGAL vector was prepared for 
ligation by double digestion with NotI and BgIII. D, schematic drawing of the vector construct. The NotI/BgIII 
double digested TyrR promotor sequence was inserted into the NotI/BgIII double digested pPTGAL vector. 
 
 
The GAL4 protein under the control of TyrR-promotor is expressed in the larval circulatory 
system (Fig.49A, B1, B2), which appears as a narrow simple blind-ending unbranched tube 
extending along the dorsal midline of the larval body that divides into anterior aorta and 
posterior heart. Aorta is lined by inner thin contractile myoepithelial cells (cardiocytes) 
followed by outer non-contractile pericardial cells. The GFP signal of the outer layers appears 
to be stronger than that of the inner layer. To identify the cells within the heart that express 
the TyrR, I performed immunohistochemical studies for the heart with two different primary 
antisera; anti-GFP, anti-bruchpilot nc82 (Fig.50).  
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Figure 49: GFP expression pattern in the TyrR-GAL4/UAS::GFP in larvae. 
A, lateral view of the third larval stage showing the GFP along the dorsal aorta which extend  in the whole length 
of the larval body; arrow refers to the posterior spiracle. B1 and B2, GFP expression pattern in the larval heart. 
GFP could be also seen in the salivary gland (C), posterior spiracle (D), and enclose the anterior spiracle (E).  
 
 
 
Figure 50: Projection of confocal stacks illustrating the GFP imunoreactivity in the 
TyrR-GAL4/UAS::GFP heart muscles. 
The heart muscles were stained immunohisto-chemically with two primary antibodies, anti-GFP panel A and 
nc82 which is anti-bruchpilot panel B. Panel C, the overlay of  both channels.  
Scale bar = 10 µm. 
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Figure 51: GFP immunoreactivity in the TyrR-GAL4/UAS::GFP larval CNS. 
A, Very weak expression could be seen in the whole CNS. B, GFP expression pattern in one of the brain 
hemispheres; weak expression could be seen in the mushroom body sub-structures; arrow refers to few somata 
clusters appearing in the lateral dorsoposterior  and medial dorsoposterior regions of the brain hemisphere. Scale 
bar = 50µm. 
          
 
 
Figure 52: GFP expression pattern in the TyrR-GAL4/UAS::GFP adults. 
A, adult female; arrow refers to moderately expressed ventral abdominal muscles. B, expression in the wing 
venations. C, adult Drosophila leg; arrow refers to the GFP in the location of the sensilla. D, whole amount of 
adult head; long arrows refer to the GFP in the ocelli; head arrow refers to strong GFP in the clypeus; GFP could 
be visualized in the labellum especially in the psuedotrachea. E, GFP also was seen in the gut cells.   
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Figure 53: GFP immunoreactivity in the TyrR-GAL4/UAS::GFP adult brain. 
A1-A3, Expression pattern of TyrR in the adult brain. A1, GFP expression pattern; A2, the brain was stained 
with nc82 antibody and; A3, the overlay of both channels. B and C, GFP expression pattern in adult brain. B, 
arrow refers to the clusters in pars intercerebralis, which are the insulin producing cells; EB, ellipsoid body; Lo, 
optic lobe; sog, subesophageal ganglion. C, arrow refers to somata conjugated with the mushroom body; head 
arrow refers to a pair of somata located on the superior slope of the oesophageal foramen.  Scale bar = 100µm. 
 
 
Very weak expression was seen in the larval CNS (Fig.51). Mushroom body substructures 
and few somata located in the lateral dorsoposterior and medial dorsoposterior regions of the 
brain hemisphere. 
In adults, GFP is visible in the abdominal muscles (Fig.52A), wing venation (Fig.52B), leg 
conjugated with sensilla (Fig.52C) and in gut cells (Fig.52E). In the head region strong GFP 
was also seen in the ocelli and proboscis (Fig.52D) as well as in the labellum and 
psuedotrachea. 
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In the adult CNS, strong GFP expression could be seen in a pair of clusters of somata, one 
each side, located at the Pars intercerebralis (Fig. 53) which are the major insulin producing 
cells in the fly (Rulifson et al., 2002). Mushroom body sub-structures are strongly labelled 
with GFP and somata clusters conjugated with mushroom body are also strongly expressed. 
Moderate expression is seen in the ellipsoid body.  
 
3.1.3.2. TyrRII expression analysis 
In Drosophila, the gene tyramine receptor II is referred by the symbol Dmel\TyrRII 
(CG16766). To amplify the TyrRII promotor region (~ 3700 bp), corresponding TyrRII sense 
and anti-sense oligonucleotides were used. The DNA containing the promotor region was 
inserted into pPTGAL vector as described before, which was used for the production of 
transgenic lines. Studying the expression pattern was performed using the UAS/GAL4 system 
(Brand and Perrimon, 1993a). The TyrRII-GAL4 line was crossed to a UAS-GFP responder 
line, thus allowing to visualize the expression of the TyrRII gene by GFP expression.  
 
 
Figure 54: Generating TyrRII promotor inserted pPTGAL4 vector. 
A, schematic drawing illustrating the TyrRII gene model and its products. B, 1% agarose gel showing TyrRII 
promotor region amplifies with PCR. C, a part of the pPTGAL vector with the GAL4 coding sequence between a 
minimum promotor (hsp70) and termination sequence (hsp70 terminaltor). The pPTGAL vector was prepared 
for ligation by double digestion with NotI and BamHI. D, schematic drawing of the vector construct. The 
NotI/BamHI double digested TyrR promotor sequence was inserted into the NotI/BamHI double digested 
pPTGAL vector. 
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Figure 55: GFP expression pattern in the TyrRII-GAL4/UAS::GFP musculature of 
larvae. 
 A, lateral view of the whole larva; arrow refers to lateral oblique muscles. B, arrows refer to GFP expression in 
the ventral longitudinal muscles in each body hemisegments from the head to the tail region. C, close lateral 
view on the musculature of the tail region, which is associated with the anus and the posterior spiracle. D, close 
ventral view on the musculature of the tail region. 
 
 
Larvae show strong TyrRII expression in certain muscles (Fig.55), including strong 
expression in the ventral longitudinal muscles in each body hemisegments from the head to 
the tail region and also strong expression is seen in the musculature of the tail region which is 
associated with the anus and the posterior spiracle. Moderate expression could be seen 
laterally in both sides in lateral longitudinal and lateral oblique muscles compared with 
ventral longitudinal muscles. 
Strong expression is seen in the striated, syncytial gut muscle fibers surrounding the gut 
epithelium (Fig. 56A,B), including a single layer of circular muscles, which are flat and 
multinucleate, surrounding the foregut. The visceral musculature of the hindgut, like that one 
of the esophagus, is circular, with irregular diagonal and longitudinal branches given off by 
the circular strands which can be assumed to function during defecation as well as for water 
reabsorbtion. Strong expression is also seen in the tracheal system of larvae (Fig. 56C). 
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Figure 56: GFP expression pattern in the TyrRII-GAL4/UAS::GFP larvae. 
A, GFP expression in the flat multinucleated circular muscles surrounded the foregut. B, GFP expression pattern 
in the musculature of the hindgut. C, GFP expression in the larval tracheal system. 
 
 
Immunohistochemical analyses revealed that the larval CNS profusely expresses TyrRII (Fig. 
57). Moderate expression was detected in the cortex of the brain hemispheres and in the 
mushroom body. Strong expression in somata forming clusters adjacent to the calyx of 
mushroom body in the dorsomedial anterior and dorsomedial posterior regions of the brain 
hemisphere. A strong TyrRII positive projection with a soma comes out from this cluster in 
both sides toward the interhemispheric junction. Three ventral unpaired median somata are 
present in each segment in the subesophageal, thoracic and abdominal neuromeres. In 
addition to the unpaired median somata, each thoracicoabdominal neuromere had a pair of 
small dorsal somata located on the dorsolateral trace and a pair of somata located on the 
dorsolateral trace of each thoracicoabdominal neuromere. 
Adults showed strong GFP expression in the male reproductive system (Fig. 58). 
Adult CNS shows strong TyrRII expression (Fig. 59-61). It is seen in the brain cortex, optic 
lobes, the protocerebrum, central complex, oesophageal foramen, antennal lobe, mushroom 
body substructures and subesophageal ganglion. In the central complex the fan-shaped body 
(FB), the noduli (no) and the ellipsoid body (EB) are strongly innervated. Conspicuously 
dense ramifications spread in the superior and inferior posterior slope surrounding the 
esophagus foramen and those ramifications are located directly posterior to the great 
commissure. Antennal lobe and antennal nerve and outer and inner medulla in the optic lobe 
also show TyrRII expression. 
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Figure 57: GFP immunoreactivity in the TyrRII-GAL4/UAS::GFP larval CNS. 
A, projection of confocal stacks illustrating the GFP expression pattern in the whole mount larval CNS. B1 and 
B2, 3D models of brain hemisphere (B, dorsal view ; C, anterior view) showing hemisphere regions located by 
colored spheres; the outline of the optic lobe is indicated by gray line; mushroom body indicated by shaded dark 
gray; (DPM), medial dorsoposterior; (DPL), lateral dorsoposterior;( DAM), medial dorsoposterior; (DAL), 
lateral dorsoanterior; (DPL), lateral dorsoposterior; (DPM), medial dorsoposterior; (BLA), basolateral 
anterior;(BLD), basolateral dorsal;(BLP), basolateral posterior; (BLV), basolateral ventral; (CM), centromedial 
(Pereanu and Hartstein; 2006). C, close view on the brain hemispheres; strong GFP is found in the 
interhemispheric junction containing the protocerebral bridge (PB); mushroom body has  GFP expression in all 
substructures including γ lobe, α/α´ lobes, calyx (c) and pedunculi. Strong expressed somata forming cluster  
adjacent to the calyx of mushroom body in the dorsomedial anterior (DAM) and dorsomedial posterior regions 
of the brain hemisphere. Moderately expressed somata are located in the dorsoanterior region of the brain 
hemisphere which referred by an arrow and in the optic lobes (Lo). D, close view on the interhemispheric region; 
Head arrow refers to strong TyrRII projection with a soma comes out from the dorsomedial-interiorly located 
somata cluster  in both sides toward the interhemispheric junction; arrows refer to fine neuronal processes 
adjacent to the mushroom body extended posteriorlly around the midline. E, GFP expression in the thoracico-
abdominal ganglia; head arrow refers to the position of unpaired median somata located along the dorsomedial 
trace of  the subesophageal, thoracic and abdominal neuromeres; arrow refers unpaired small median somata 
located on the centrolateral trace of each thoracicoabdominal neuromere; filled head arrows refer to somata 
located on the dorsolateral trace of each thoracicoabdominal neuromere. Scale bar = 150mm. 
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Figure 58: GFP expression pattern in male and female reproductive system of  TyrRII-
GAL4/UAS::GFP adult. 
A, schematic drawing showing structure of male reproductive system.   B, GFP expression pattern in testes 
which is referred  by arrows (schematic drawing is modified from  http://flybase.org).   
 
 
 
Figure 59: GFP immunoreactivity in the TyrRII-GAL4/UAS::GFP adult brain. 
A1-A3, single optical sections of the central brain; in the central complex the fan-shaped body (FB), the noduli 
(no)and the ellipsoid body (EB) are strongly innervated; conspicuously dense ramifications spread in the 
superior and inferior posterior slope  surrounding the esophagus foramen and those ramifications are located 
directly posterior to great commissures; A1, the subesophageal ganglion (sog) is innervated by  TyrII, the GFP 
could be seen along the ventral midline of the sog from which fine neuronal processes extending throughout the 
sog;  strong GFP which was seen in the cortex  is referred by head arrow in all optical stacks; p, pedunculi; A3, 
antennal lobe (al) is innervated, a fine commissure arising from the oesophageal foramen is directing into the 
antennal lobe is referred by arrow; strong GFP could also be seen in the antennal nerve(Ant ne); cc, the central 
body complex; B1 and B2, single optical sections of the optic lobe; the outer and inner medulla (me) in the optic 
lobe are innervated while the lobula (lo) of the optic lobe is not innervated by the GAL4-expressing cells. Scale 
bar = 150µm. 
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Figure 60: GFP immunoreactivity in the TyrRII-GAL4/UAS::GFP adult brain shown in 
confocal  stacks. 
Focusing on these stacks reveal that the TyrRII expression appear in optic lobes, protocerebrum, central complex 
, oesophageal foramen, antennal lobe, mushroom body substructures and subesophageal ganglion which could be 
more obviously detected from the Z-projection of those confocal stacks, H, in which the GFP expression appear 
allover the brain. Scale bar 150 mm. 
 
 
 
Figure 61: GFP immunoreactivity in thoracico-abdominal ganglion  of  TyrRII-
GAL4/UAS::GFP  adult stage  shown by a projection of confocal  stacks. 
Scale bar = 100mm 
 
 
3.1.3.3. TyrRIII expression analysis   
In Drosophila, this gene is referred  by the symbol Dmel\CG7431. To amplify the TyrRIII 
promotor region (~3200bp) corresponding TyrRIII sense and anti-sense oligo-nucleotides 
were used. The DNA containing the promotor region was inserted into the pPTGAL vector as 
described before.  
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Figure 62: Generating TyrRIII promotor inserted pPTGAL4 vector. 
A, schematic drawing illustrating the TyrRIII gene model and its products. B, 1% agarose gel showing TyrRIII 
promotor region amplifies with PCR. C, a part of the pPTGAL vector with the GAL4 coding sequence between a 
minimum promotor (hsp70) and termination sequence (hsp70 terminaltor). The pPTGAL vector was prepared 
for ligation by double digestion with NotI and BamHI. D, schematic drawing of the vector construct. The 
NotI/BamHI double digested TyrRIII promotor sequence was inserted into the NotI/BamHI double digested 
pPTGAL vector. 
 
 
Larvae show strong TyrRIII expression in oenocytes (Fig. 63). They are large cells attached to 
the basal surface of the lateral epidermis. They are arranged in clusters of ~6 cells per 
abdominal hemi-segment. Using Nile Red (Nile blue oxazone) staining, which stains 
intracellular lipids, oenocytes were found to contain lipid droplets. Regions of the gut, 
including the proventriculus and anterior gut, malpighian tubules and salivary glands also 
display strong GFP expression (Fig.64).  
In the larval CNS, the whole neuropile strongly expresses GFP (Fig.65), mainly in the 
mushroom bodies. Strongly expressed arborizations are visualized around the esophagus. 
Strong GFP expression could also be seen in the thoracico-abdominal ganglion. Three pairs of 
somata, one pair in each thoracic neuromere, reside ventro-medially in the cortex beneath the 
centro-intermediate trace. Each soma sends a neuron toward the dorsolateral trace. GFP-
positive somata are located on the dorsolateral traces in the thoracic and abdominal 
neuromere. 
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Figure 63: Oenocytes expressing GFP in the TyrRIII-GAL4/UAS::GFP larvae. 
A, GFP expression in the whole mount 3-rd larval stage; arrow refers to the oenocytes attached to the basal 
surface of the lateral epidermis each hemisegment. B, optical image using confocal microscope for a oenocytes 
cluster which consists of about 6 nucleated cells. C-E, oenocytes cluster with GFP expression (C), positively 
stained with Nile red which stain its intracellular lipid and overlaying of both photos (E).  
 
 
 
Figure 64: GFP expression pattern in TyrRIII-GAL4/UAS::GFP larvae. 
GFP could be seen in salivary gland (A), in the malpighian tubule (B), in the foregut especially the 
proventriculus. D-F, TyrRIII expression in the proventriculus; D, GFP expression pattern; E, proventriculus 
positively with Nile red staining; and F, overlay of GFP and nile red channels. 
 
Adults also show expression in oenocytes (Fig.66). The oenocytes are uninucleated and have 
dense cytoplasm with accumulative lipid granules. GFP was also observed in the adult 
salivary glands (Fig.67A) and legs, especially in the articulation areas (Fig. 67B). 
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Figure 65: GFP immunoreactivity in the TyrRIII-GAL4/UAS::GFP larval CNS. 
A1-B3, projection of confocal stacks illustrating the GFP expression pattern in the CNS with maximum intensity 
(A1-A3) and average intensity (B1-B3). C1-C3, projection of confocal stacks showing the GFP expression 
pattern in the brain hemisphere.  A1 and B1, GFP expression pattern; A2 and B2,  dsRed photos as synaptic 
neuropile were stained by nc82 anti-bruchpilot; A3 and B3, overlay of GFP and dsRed photos; in panels A1 to 
C3 the larval CNS was tilted about 45° to the right to better visualize the bottom and the upper regions of the 
CNS. D, schematic drawing of the TyrRIII expression in the larval CNS.  Scale bar = 50 µm. 
 
 
Moderate expression was seen in the adult brain (Fig.68). Mushroom body sub-structures are 
labelled. Moderately expressed somata were seen in the lateral horn, posterior superior- and 
posterior medial protocerebrum and in the suboesophageal ganglion. Strong expressed somata 
are located ventromedially in the antennal lobes. Antennal lobes are moderately innervated by 
TyrRIII positive neurons 
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Figure 66: GFP expression pattern in the TyrRIII-GAL4/UAS::GFP adult oenocytes 
A, GFP expression in the oenocytes which appear as bands of cells near the sternites. B, oenocytes positively 
stained with Nile red which stain its intracellular lipid. C, overlay of GFP and DsRed photos. D, optical image 
using confocal microscope illustrating the adult oenocytes. Arrows in panels A-D are referring to the position of 
the oenocytes.  
 
 
 
 
Figure 67: GFP expression pattern in TyrRIII-GAL4/UAS::GFP adults. 
A, GFP in adult salivary gland. B, adult leg; arrows referring to the GFP in the articulation areas.  
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Figure 68: GAL4 immunoreactivity in the TyrRIII-GAL4/UAS::GFP adult CNS. 
psmpr, posterior superior protocerebrum; lh, lateral horn; plmpr, posterior lateral protocerebrum; al, antennal 
lobe; vlpr, ventrolateral protocerebrum; sog, subesophageal ganglion; arrow refers to a neuron innervate the 
antennal lobe; head arrows refer to somata located ventromedially in the antennal lobes. 
 
3.2. RNAi –based experiments 
To evaluate the function of the receptor Dmel\octß2R (CG33976), GAL4-UAS binary system 
was used. By which it is possible to interfere with the gene function practically anywhere and 
anytime during development. The line Octß2R-RNAi-UAS (vdrc stock centre Vienna, 
Australia) in which the insertion location was on the second chromosome was crossed to (yw; 
P{tub-GAL4;TM3, sb}) driver line and the line RNAi-Nos-RD was used as control for this 
experiment. Ten males and five females were used for crossing.  The flies were allowed to 
remain in the same food vial two days. First, the number of eggs was counted every two days 
and vials were inspected daily and the relevant event and date on which they occur was noted 
as, the beginning of 1st larval instar, 3rd larval instar wandering, prepupation formation, 
pupation, eclosion and pupal lethality. Ten males and ten females from the first generation 
were allowed to cross in new food vial and the number of laid eggs was counted every day.  
From the previous data, the percentage of hatchability and fecundity were determined. Next, 
the morphology and locomotor activity of the first generation was examined. 
 No phenotypic or developmental abnormality could be detected in the first generation. The 
number of laid eggs in 10 days , number of hatched adults, males and females, the percentage 
of hatchability and the percentage of first generation fecundity were showed in table(1). 
The first line had mean number of laid eggs (238) more than line 2 (125) and the control 
(200). Line1 had mean number of hatched adult (210) including males (95 ~45.2%) and 
females (115~ 54%) more than line 2 which had (71) hatched adults, including males (35~ 
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49.2%)   and females (36 ~ 50.8 %) and the control which had (158) hatched adults, including 
( 52 ~26 %)  males and (106 ~ 54 %)  females. Percentage of hatchability was calculated;   for 
line1 ( 88.2 %); for line2  (56.8 %); and for the control ( 79 %) and like the other parameters it 
was lower in line2 than line1. Percentage of fecundity was very low in both line1 and line2; 
but it was lower in line1 (10.42 %) than line2 (11.1 %) and the control (10.9 %). By following 
these eggs, no development and hatchability was occurred. As shown in Figure (69), the 10-
days old eggs have abnormal egg shell. 
 
Table 1: The main parameters measured for Octß2R-dsRNAi×UAS/GAL4-tubp line 1 
and 2 compared with NOS-RD as control 
including mean number of eggs laid by 10 females in 10 days, mean number of hatched adults, males and 
females, percentage of hatchability and fecundity. 
 
 
Parameter 
 
dsRNA 
DmOctß2R 
line 1 
 
dsRNA 
DmOctß2R 
line 2 
 
RNAi- Nos-rd 
 
Mean no. of laid eggs in 10 days. 
 
 
238 
 
125 
 
200 
 
Mean no. of hatched adults.                        
 
 
210 
 
71 
 
158 
 
No. of hatched males 
 
95 (45.2 %) 
 
35 (49.2 %) 
 
52 (26 %) 
 
No. of hatched females 
 
115 (54 %) 
 
36 (50.8 %) 
 
106 (54 %) 
 
Percentage of  hatchability 
 
88.2 % 
 
56.8 % 
 
79 % 
 
Percentage of fecundity of the 1st 
generation 
 
10.42 % 
 
11.1 % 
 
10.9 % 
 
 
Figure 69: Pattern of eggs laid by the 1st generation Octß2R-dsRNAi×UAS/GAL4-tubp. 
Arrow sin A and B refers to the abnormal pattern of the egg shell. 
 
PDF created with FinePrint pdfFactory trial version http://www.pdffactory.com
Chapter 3: Results 82 
 
 
Figure 70: Nine frames  of  Frame /second  snapshots converted video showing the 
attempt of  female  Octß2R-dsRNAi×UAS/GAL4-tubp. 
Adult try to use the left foreleg  and followed by many failed attempts to use the right  middle leg, in which the 
insect move the right middle leg  back and forth  followed by strongly  upward movement ; arrows refer to leg 
movement direction; dashed lines refer to upward directed leg movement.     
 
 
As showed in Figure (70), adult Drosophila try to go up within the new transparent food vial.  
Adult stage was suffering during movement. To demonstrate this, the locomotor activity of 
adult flies in a normal food vials was video- taped from the front view; in which Drosophila 
flies (males, females and virgin females) walked freely in new food vial. All videos were 
captured at 24°C and Aimer software was used to generate one - second frames. These frames 
were used to evaluate the adult movement and to determine the movement speed and angle. 
Adults try to use the left foreleg  and followed by many attempts to use the right  middle leg, 
in which the insect move the right middle leg about five times forward-backward and then 
upward (Fig.70;G-I).  This followed by attempts with the left middle leg. However, the adult 
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remain in the position and there is no change in the direction of the longitudinal body axis. 
Using ImageJ frame-by-frame analysis, the footprint could be made (Fig.71) which indicated 
that the adult Octß2R.dsRNAi-UAS/GAL4-tubp  tried to use the middle leg by back and forth 
movements followed by the hindleg and also the asymmetrical resting positions  of both fore- 
and middle leg. The  movement after 47 sec was with distance ~ 0.7 mm and angle ~ 21.24° 
to the right direction.    
 
Figure 71: pattern of footprint from a fly obtained by frame by frame analysis for 47 
frames (converted from video using Aimer software with frame/sec snapshots) using 
ImageJ software. 
A, maximum projection of stacks image  illustrating the footprint indicate the asymmetrical resting positions of 
legs; the footprint of the forelegs was shown in red colour, of the middle leg  in blue colour and of the hind leg in 
green colour. B, minimum projection of stacks image illustrating footprint; the black dashed line indicate the 
longitudinal body axis; the black arrow indicate the direction of movement. Scale bar = 2.6mm.  
 
The trails of courtship  were  video taped and Aimer software was used to convert each video 
into one/second frames. From these videos it could be seen that there is a strong relationship 
between the locomotor activity and the courtship (fig.72). First, males tried to tap females  
with their forelegs. Followed by the love-song (wing vibrations with certain intervals). Next, 
females slowed down their movement, they remained almost in the same position. Males tried 
to lick females’ genitalia. Female were then run away from males. But males were not able to 
keep up with their females and then males lose the ability to adjust their position to females 
(male tried to move the middle leg back and forth many times and keep the forelegs fest to 
adjust his position and movement toward his female) this led to the incomplete courtship. 
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Figure 72: Failure of  the first genetration Octß2R-dsRNAi×UAS/GAL4-tubp courtship. 
  A-I, nine snapshots taken  snapshot/second  using Aimer software.  A, male begin love song by vibrating his 
right wing with certain intervals. B, male tried to tap female with his foreleg to recognize her. C-E, male 
continued with his love song and tried  to lick female genitalia; long arrow refers to the male proboscis. F, 
female begin run away from male which normally occur in the Drosophila melanogaster courtship   ; short 
arrow refers to the trail of male to adjust his position to female but the leg muscles are not strong enough to 
manage the courtship situation. G-I, male move his middle legs back and forth in a repetitive failed attempts to 
adjust his body to females but he could not.   
 
 
 
3.3. Pharmacological characterization of octopamine receptors using human embryonic 
kidney cells (HEK 293 cells). 
The Lymnaea stagnalis OAR was supplied by colleagues (Hiripi et al., 1998). Regarding to 
Ocß2R and Ocß3R, the corresponding cDNA was isolated by reverse transcription PCR, 
which was done using the total RNA. The cDNA was used as template for subsequent PCR 
reactions using specific sense and anti-sense primers to amplify the full-length gene coding 
sequence. The full-length coding region of the gene was inserted into the mammalian 
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expression vector pEAK10CV. Thereafter, transiently transfected HEK-293 cell lines were 
established to express the Octß2R or Octß3R genes. HEK 293 cells were cotransfected with 
the octopamine receptor-coding plasmid pEAK 10CV and the reporter-coding plasmid pCRE-
SEAP.  
 
3.3.1. Pharmacology of Lymnaea OA receptor  
Agonists and antagonists were applied at concentrations ranging from 10-3 to 10-9 M, resulting 
in cAMP-inducible, high level SEAP expression. About 12-24h after applying drugs, SEAP 
was quantified based on the hydrolysis of pNitrophenyl phosphate producing a yellow end 
product, which was measured spectrophotometrically at 405 nm. 
Non-linear regression analysis of the data revealed a sigmosoidal increase in SEAP end 
product with increasing agonist concentration, which resembles the increase in intracellular 
cAMP levels. Octopaminergic agonists such as NC5, NC7, demethylchlordimeform and 
synephrine were able to induce SEAP expression in a dose-dependent manner. NC5 and NC7 
have higher affinities than synephrine, which in turn has a higher affinity than 
demethylchlordimeform (Fig 73,B). The corresponding EC50 values are NC5 4.84×10-7 M, 
NC7  1.52×10-7 M, synephrine 4.88×10-7 M and demethylchlordimeform 2.74×10-7 M. 
Octopamine has a higher affinity than dopamine, tyramine and serotonin (Fig ,73A). In 
addition to the effects of octopaminergic agonists on the induction of SEAP expression, I 
studied the effects of increasing concentrations of octopamine antagonists on the SEAP 
expression of transfected HEK293 cells challenged with a fixed concentration of octopamine 
(0.1M) while the concentration of antagonists varied. Seven octopaminergic antagonists: 
epinastine, phentolamine, chlorpromazine, metoclopramide, yohimbine, rauwolscine, and 
mianserin were tested, all of them are able to reduce the SEAP expression in a dose- 
dependent manner. Yohimbine has the highest affinity followed by metoclopramide > 
phentolamine > rauwolscine > chlorpromazine > mianserin > epinastine.  
The EC50 values for biogenic amines and other ligands including octopaminergic agonists 
and antagonists are summarized in table (2).  In general DL-synpherine, NC5, NC6, NC7 and 
the antagonist Metoclopramide have higher affinity to Lymnaea OA receptor than other 
ligands.  
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Figure 73: Pharmacological features of Lymnaea OA receptor evaluated by SEAP  HEK 
expression system. 
After transfection, cells were challenged with increasing concentrations of biogenic amines (A), or 
octopaminergic agonists (B).  
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Table 2: Pharmacological properities of  Lymnaea octopamine receptor OA. 
 
Applied ligand          EC50 value [µM] 
Biogenic amines 
                          
Tyramine 12,460 
DL-synpherine                4,880 
DL-octopamine               3,028 
Dopamine                        16,840 
Serotonin                         177,610                            
Other ligands                     
                                                                                                  
BTS                                 95,110 
Desmethyl                       27,400    
Naphazoline                    4,286    
NC4                                1,090 
NC5                                0,484 
NC6                                0,294                                 
NC7                                0,152 
NC9                                4,710 
NC12                              2,767 
Phentolamine                  7,602                      
Rauwolscine                   11,530 
Metoclopramide             0,711 
Epinostine                       40,330   
Mainserin                        36,260 
Yohimbine                      0,298 
Chlorpromazine              13,970   
Amitraz 31,540                                                           
 
 
3.3.2. Pharmacology of  Drosophila  Octß2R   
 
HEK-293 cells were transfected with a plasmid containing the coding region of the gene 
under control of the CMV promotor. This plasmid was cotransfected with a reporter plasmid 
where SEAP is under control of cre elements.  
Ligands were applied at concentrations ranging from 10-3 to 10-9 M, resulting in cAMP-
inducible, high level SEAP expression. Dopamine, Tyramine and synpherine have higher 
affinity than octopamine, which in turn has higher affinity than serotonine (Fig.74). The EC50 
values were octopamine 1.21×10-4 M; Dopamine 1.95×10-5 M; Tyramine 4,41×10-5 M; 
Serotonin 4.59×10-4 M; synephrine 4.88×10-5 M. The effects of increasing concentrations of 
octopamine antagonists on the Octß2R expression of transfected HEK cells was also studied.  
I tested the same set of antagonists as for the Lymnaea OA receptor. Yohimbine has the 
highest affinity followed by phentolamine > mianserin > rauwolscine > metoclopramide > 
chlorpromazine > epinastine (table, 3).  
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Figure 74: Pharmacological features of Drosophila Octß2R receptor evaluated by SEAP  
HEK 293 expression system. 
After transfection , cells were challenged with increasing concentrations of biogenic amines octopamine, 
tyramine, dopamine, synpherine, or serotonine. 
 
Table 3: Pharmacological properties of Drosophila  Octß2R. 
 
Applied ligand                       EC50 value [µM] 
Biogenic amines 
Tyramine                                44,10
DL-synpherine                       48,80 
DL-octopamine                      121,00 
Dopamine                              19,50
Serotonine                              459,00                           
Other ligands                      
                                   
BTS                                         14,40 
Desmethyl                 0,283   
Naphazoline                            0,283 
NC3                                        69,70
NC4                                        38,80
NC5                                        91,10
NC6                             138,00                               
NC7                                        0,441
NC9                                        4,71
NC12                                      168,00
Phentolamine                          0,273
Rauwolscine                            1,290
Metoclopramide                      1,320 
Epinostine                               40,30  
Mainserin                                0,488 
Yohimbine                              0,128
Chlopromazine          12,90 
Amitraz 171,000                                                           
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3.3.3. Pharmacology of  Drosophila  Octß3R 
   
HEK-293 cells were transfected with a plasmid containing the coding region of the gene 
under control of the CMV promotor. This plasmid was cotransfected with a reporter plasmid 
where SEAP is under control of cre elements.  
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Figure 75: Pharmacological features of Drosophila Octß3R evaluated by SEAP HEK 
expression system. 
After transfection , cells were challenged with increasing concentrations of biogenic amines(A),   
octopaminergic agonists (B) or antagonists (C). 
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Table 4: Pharmacological properties of  Drosophila Octß3R. 
 
Applied ligand                       EC50 value [µM] 
Biogenic amines 
Tyramine                                4,71
DL-synpherine                       3,55 
DL-octopamine                      1,13 
Dopamine                               1,43
Serotonin                                1,51                          
Other ligands                      
                                    
BTS                                         4,47 
Desmethyl                               0,522    
Naphazoline                            0,079 
NC3                                        0,709
NC4                                        7,170
NC5                                        48,80
NC6                                        93,20                               
NC7                                        5,00
NC9                                        3,02
NC12                                      19,80
Phentolamine                          0,022                     
Rauwolscine                           5,210
Metoclopramide                     2,890 
Epinostine                              23,40 
Mainserin                               0,551 
Yohimbine                             1,090   
Chlopromazine                      0,014 
Amitraz                                  171,000                                                           
  
As known for native octopaminergic receptors, octopamine has a higher affinity than tyramine 
> serotonin = synephrine > dopamine (Fig 75, A). 
Octopaminergic agonists such as NC3, NC4, NC5, NC6 and NC7 were able to induce SEAP 
expression in a dose-dependent manner. NC3 (EC50 7.09×10-7M) has higher affinity than 
NC7 (EC50 5.00×10-6M), which in turn has higher affinity than NC4 (EC50 7.17×10-5M) > 
NC5 (EC50 4.88×10-5M) > NC6 (EC50 9.32×10-5M) (Fig 75, B). The effects of increasing 
concentrations of octopamine antagonists on the Octß-3R receptor of transfected HEK cells 
was also studied. Chlorpromazine has the highest affinity followed by phentolamine > 
mianserin > yohimbine > metoclopramide > rauwolscine > epinastine (Fig.75,C). 
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4. Discussion 
Taking the advantage of genetic methods available for the fruit fly Drosophila melanogaster, 
I tried to characterize the physiological significance of three families of G-protein coupled 
bioamine receptors, the octopamine, the tyramine and the dopamine receptors. To identify 
their physiological role, but also to find new targets for insecticides. I tried to elucidate their 
expression patterns, their pharmacology and their physiological relevance using a set of 
different approaches. To achieve these goals, I primarily used the GAL4/UAS system for in 
vivo targeting of gene expression in a spatially controlled manner. This system was adapted 
for use in Drosophila by (Brand and Perrimon, 1993a) in which the GAL4, the yeast 
transcription activator, activates the specific expression of a target gene placed under the 
control of UAS promotor. This bipartite system is advantageous because each part of the 
system is maintained in separate parental lines which are viable since no activation is possible 
if the system is uncoupled. This system was used in my study to analyze the gain-of-function 
and the loss-of-function of genes coding the biogenic amine receptors as well as their 
expression pattern using promotor –GAL4 fusion constructs. 
 
4.1. Octopaminergic/tyraminergic receptors:  
The biogenic amine octopamine is known as a major neurotransmitter and neuromodulator in 
the invertebrates (David and Coulon, 1985). It is belived to modulate almost every peripheral 
organ and most sense organs. The total, four genes for octopamine receptors were identified; 
namely, Oamb, Octß1R (OA2), Octß2R, and Octß3R (Maqueira et al., 2005).  Octopamine, 
together with tyramine, is the invertebrate counterpart of adrenaline/noradrenaline that is very 
important transmitter/hormone in vertebrates. Tyramine is a monoamine synthesized from the 
precursor, the amino acid tyrosine by the action of the enzyme, tyrosine decarboxylase 
(TDC). The tyramine act as a precursor for octopamine synthesise by the action of the 
enzyme, tyramine-ß-hydroxylase (Roeder, 1994, 1999). 
Thus, octopaminergic containing cells will contain tyramine as a precursor and therefore both 
tyramine and octopamine may be released from the same neurons as co-transmitters. On the 
other hand, some tyramine containing cells do not contain octopamine (Downer et al., 1993; 
Nagaya et al., 2002). 
In this work, I found some new aspects regarding the role of selected octopamine and 
tyramine receptors. At the beginning of my thesis, there was a fundamental discrepancy 
between earlier studies with larger insects regarding the physiological significance of 
octopamine and tyramine and the phenotype of Drosophila null mutants. Whereas these 
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earlier studies reported modulation of almost every organ in insects (Roeder, 1999), the 
octopamine deficient flies are almost wild type like  (Monastirioti et al., 1996). My studies 
may help to fill this gap in some aspects. Most important may the work dealing with one of 
the octopamine receptors, namely the Oct2ßR. It may give us especially a first indication 
regarding octopamine and tyramines role in muscle physiology. The Oct2ß receptor gene is 
expressed  in the entire muscular system of Drosophila larvae including those which are 
longitudinally and obliquely arranged along the body axis and in transversally arranged 
muscles orthogonally orientated to the body axis, whereas tyraminergic receptors expressed 
only in: (1) the segmentally repeated ventral longitudinal muscles which play a major part of 
the larval musculature used in crawling, (2) lateral longitudinal muscles, and (3) lateral 
oblique muscles in each body hemisegments from the head to the tail region in addition to the 
musculature of the tail region which is associated with the anus and the posterior spiracle.  In 
the light of other studies, octopamine and tyramine have opposite effects on muscles, whereas 
octopamine enhance the contraction of muscles tyramine has the opposite effect (Nagaya et 
al., 2002) but Drosophila larvae require normal octopamine/tyramine function in regulating 
walking activity (Saraswati et al., 2004; Fox et al., 2006). 
In Drosophila, flies with a null mutation in the gene encoding the enzyme tyramine ß- 
hydroxylase have reduced octopamine levels and increased tyramine levels (Monastirioti et 
al., 1996) and they show a slight locomotion defect (Saraswati et al., 2004).  This implies that 
the major role of tyramine is to receive the informations from the sense organs and inhibit the 
movement accordingly. On the other hand, whole larval body-wall muscles express Octß2R. 
Together, these results suggest that octopamine and tyramine are involved in the initiation and 
modulation of the coordinated activities involved with crawling in Drosophila larvae (Fox et 
al., 2006), who used mutants defective in transmitter synthesis.  
In adults, only two octopamine receptors show expression in muscles, namely the oct2ß and 
the Oamb receptors. I could show that these receptors are expressed in a complementary 
fashion. Oct2ß receptors are present in much more skeletal muscles than Oamb ones. It 
appears that the Oct2ß receptors are exclusively expressed in those muscles that are relevant 
for walking. Within the leg, Oamb receptors are present in other leg muscles. This broad 
expression of the Oct2ß may be the reason for the deficits I observed in the corresponding 
RNAi flies. I record muscle weakness of the legs and inability of the insects to go up against 
the gravity in which adult Drosophila attempt many times to move up for ~ 10min without 
any change in the position. In addition there are no, or only marginal changes in the direction 
of the longitudinal body axis, which reflects the impact of this gene on the coordination and 
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consistency of the movement in adult Drosophila. More over, during courtship, males were 
not able to keep up with females because they could not move their legs properly and the 
males then lost the ability to adjust their position, which leads to the failures in courtship. This 
may suggest a role of octopamine in Drosophila movement and the strong relationship 
between locomotion and courtship. For this reason, i record zero hatchability in their eggs. 
Octopamine is known to initiate or modulate the rhythmic behaviour in other insects, leeches, 
and earthworms (Hashemzadeh-Gargari and Friesen, 1989; Ramirez and Pearson, 1991; 
Monastirioti et al., 1995; Roeder, 1999; Mizutani et al., 2002). The role of octopamine in 
initiation and maintenance of rhythmic behaviour as walking and flying in insects (Sombati 
and Hoyle, 1984a, b), swimming in crustacean (Mulloney et al., 1987) and chewing in 
molluscs (Kyriakides and Mccrohan, 1989) was reported. My own experiments have not yield 
a comparable result at the level of the corresponding receptors. In addition, I see that TyrR is 
strongly expressed in the heart muscles. Heartbeat in Drosophila, although myogenic (Dowse 
et al., 1995; Gu and Singh, 1995), is modulated by neurotransmitters which suggest that 
tyramine may be involved in such group of neuromodulators. Thus this receptor might be the 
molecule that transmits the effects of octopamine/tyramine in this organ.  
Tyramine receptor 2 was strongly expressed in the central complex (CC), which is located in 
the center of the supraesophageal ganglia. The CC forms connections to a variety of brain 
centres. It is a control center for many different behavioural response (motor outputs) and 
receive visual input (Strauss, 2002). Mutants with CC structural abnormalities are impaired in 
visual- pattern memory.   
In addition to the role in movement control, octopamine and tyramine are thought to play an 
important role in metabolic control. Octopamine is the hormone of feast, being antagonistic to 
insulin. Glycogen and triglycerides are the energy reserves in animals including insects. 
Glucose is stored in a polymeric form, glycogen, that can easily be degraded on demand to be 
used as a glycolytic fuel (Steele, 1982). Fatty acids are stored as triglycerides in fat body and 
in oenocytes (Gutierrez et al., 2007) that can be used for energy production through ß-
oxidation (Athenstaedt and Daum, 2006). The process of energy mobilization is converting 
stored glycogen and triglycerides into heamolymph trehalose and diglycerides, respectively. 
This process is controlled by the neurohormone octopamine which increase the cAMP or Ca2+ 
(Roeder, 2005). Octopamine stimulates the lipid mobilization in several insects (Fields and 
Woodring, 1991; Orchard et al., 1993; Socha et al., 2008). OA induces the energy 
mobilization and tyramine induces lipid storage which suggests that octopamine and tyramine 
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have opposite effect on the lipid content and both generate lipid metabolism program facing 
the energy demand during larval stage.  
Two major hormonal system in the Drosophila brain regulate the metabolic state, namely the 
insulin and the adipokinetic hormones axes (Rulifson et al., 2002). Whereas the insulin 
producing cells are homologous to the ß-cells of the pancreas, the adipokinetic hormone 
producing cells in the corpora cardiaca are homologous to the alpha cells of the pancreas. 
Thus this interconnected system represents a functional islet of Langerhans within the brain of 
the fly. A recent genome- wide RNAi screening in adult Drosophila with the goal to identify 
genes affecting the fat content (obese and lean flies) performed by Pospisilik et al. (2010) 
revealed a large number of genes that regulate fat content in they are downregulated. Even if 
the RNAi is restricted to specific organs, such as the brain, muscle, oenocytes- and /or fat-
body, corresponding effects could be seen. Among them, two octopamine/tyramine receptors 
(TyrR and oa2) showed reduced body fat content in response to RNAi knockdown.  
I observed very strong expression of the TyrR gene in the major insulin-producing cells in the 
Pars intercerebralis located in the median protocerebrum. Within these cells, maximal 
expression could be seen. In mammals, insulin is a hormone that has effect the metabolism. 
Insulin causes cells in the liver, muscles and fat tissue to take up glucose from the blood, 
storing it as a glycogen in the liver and muscles and stop use of fat as a energy source. When 
insulin is absent or low, glucose is not taken up by body cells and the body begins to use fat a 
as energy source. In flies, killing these cells induces an obese phenotype. Overexpression of 
the TyrR in these cells should have the same effect, as it is known that this receptor is 
negatively coupled to activation of adenylate cyclase (Saudou et al., 1990). This would lead to 
a tyramine induced silencing of insulin secretion, thus showing the same phenotype. 
Removing the receptor from these cells would have the opposite effect, simply because the 
inhibitory effect of tyramine on the insulin-producing cells is removed. This is observed in 
these flies (leanness). Regarding the role of oa2, we have currently no idea, because it is 
coupled to activation of adenylate cyclase. It is possible, that the receptor is also present in the 
AKH-producing cells that are antagonistic to the insulin producing cells.  
Another tyramine receptor might also be part of the metabolic control system of the fly, as it 
is expressed in the insulin-producing cells but also in the oenocytes, the functional equivalent 
of the mammalian liver in the fly (Gutierrez et al., 2007).  These receptors are the TyrRIII 
receptors. In this study, we reported strong GFP expression in clusters of oenocytes in each 
abdominal hemisegment of TyrRIII-GAL4/UAS::GFP larvae and adults. And these clusters of 
oenocytes were verified for their lipid storage by using Nile Red staining which stains 
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intracellular lipids. This may have important implications for the much-hypothesized link 
between the insulin and storing fat, or in other words, obesity. Flies supposed to have the 
metabolic regulators parallel to those in mammals; in Drosophila the food which not digested 
and absorbed is stored in the fat body. The fat body acts like the mammalian liver and the 
white adipose tissue that storing large reserves of glycogen and lipid. The same function is 
played by a special clusters of cells called oenocytes accumulate lipids during starvation and 
are proposed to perform hepatocyte-like functions in lipid processing (Gutierrez et al., 2007). 
A signal than comes to inform the CNS of the energy status of the organism. The CNS 
regulates the physiological and behavioural outputs to maintain the organism in optimal 
energetic state. This energy circuit in the flies is similar to that of mammals (Kaun and 
Heberlein, 2009). 
My immunohistochemical studies revealed candidates that may function as autoreceptors. In 
this study, immunostaining revealed that the larval CNS had profuse tyramine- positive 
expression (TyrRII) in the brain, subesophageal ganglia and thoracico-abdominal ganglia. In 
the brain, there was a cluster of somata in the ventro-anterior side of each hemisphere and 
several weakly stained somata in the dorso-anterior side and in the dorsal side. Ventral 
unpaired median neurons were present in each thoracio-abdominal neuromere. This 
distribution of somata in the larval brain is typical for octopamine/tyramine producing cells 
(Nagaya et al., 2002). In addition, I found that Octß3R is expressed in unpaired somata that 
are situated at the ventral mid-line or the dorsal mid-line of the subesophageal ganglion were 
visualized, these called VUM and DUM neurons in insects (Hoyle, 1975; Hoyle and Barker, 
1975; Hoyle et al., 1975; Braünig and Pflüger, 2001).  Subesophageal VUM/DUM neurons 
innervate most parts in the insect brain and a subpopulation of them is octopaminergic 
(Hoyle, 1975; Hoyle and Barker, 1975; Braünig and Pflüger, 2001). We found that these 
DUM neuron is bifurcated in the midline to innervate the antennal lobes, rolled up inside and 
ascend toward  median protocerebrum, the same result was obtained in locust Locusta 
schistocerca in which the DUM neurons provide ascending processes to innervate the 
antennal lobes (Braünig and Burrows, 2004). 
One very asthonishing result was that numerous octopaminergic and tyraminergic receptors 
are expressed within the mushroom body (MB) of the fly. In Drosophila, mushroom bodies 
are critical for olfactory learning and memory (Han et al., 1996; McGuire et al., 2005). The 
primary olfactory inputs are conveyed from the antennal lobes to the MB and to the lateral 
horn. Octopaminergic inputs were reported to be important to convey the olfactory 
informations to the MB. The octopaminergic innervation of the MB are required for 
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association of odours with sugar in an appetitive (or aversive for dopaminergic receptors such 
as punishment) conditioning procedure, in which one or two odorants is typically paired with 
sugar as a reward or electrical shock as a punishing stimulus (Schwaerzel et al., 2003). But it 
appears that octopaminergic and tyraminergic systems do not have a role in place learning 
(Sitaraman et al., 2008; Sitaraman et al., 2010). The cAMP/PKA activity within the 
mushroom body in response to specific neuromodulators is critical for memory formation 
(McGuire et al., 2005). Not only Oamb, but also most other receptors for octopamine and 
tyramine are present within these cells. Currently, we can’t decide if expression of these 
receptors is restricted to certain subpopulations of cells within this structure or if it is 
mushroom body wide. This expression pattern can be of great interest for learning 
physiology, because these receptors have different intracellular signalling pathways.  
In Drosophila larvae, only two octopamine receptors show expression in tracheal system, 
namely the oa2 and the Oamb receptors. Whereas oa2 expressed  especially in the main 
branches of the tracheal system, Oamb is  strongly expressed in three levels of the tracheal 
system; the secondary- and tertiary branches and the blind ending terminal branches 
(tracheoles), including a lot of visceral branches and transverse connectives forming a dense 
network. This network is formed by a series of successive branching and fusion events. 
During this process, specialized tip cells lead the migration of new branches and mediate their 
interconnection. During the branch fusion process, some tip cells become specialized as 
“fusion cells” and convert themselves into seamless tubes that span the branch fusion joint. 
Other tip cells become specialized as “terminal cells” that go on to form branched, blind-
ended seamless tubes that ramify extensively on target tissues, and act as the site of gas 
exchange. The entire organ is made of epithelial cells only, forming a single layer around the 
central airspace which suggests that octopamine receptors may be involved in the branching 
and fusion process of the insect tracheal system. The presence of OARs in the tracheal system 
and  subsequent increase in cAMP upon OA binding have been proposed by (Zeng et al., 
1996).  
In man and mammals adrenergic receptors, which parallels OARs/TARs in invertebrates,  are 
expressed on different cell types in respiratory system including epithelial cells, smooth 
muscle cells  (Svedmyr, 1990; Barnes, 1999; Maris et al., 2006) and mediate various 
important physiological functions in tracheal epithelium (Folkert and Nijkamp, 1998). In 
insects, respiratory epithelial cells have important role in defence against airborne pathogens 
not only through acting as a physical barrier but also through different molecules such as 
different antimicrobial peptides and lysozymes (Wagner et al., 2008). The same function was 
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also reported in humans by Giebelen et al. (2008)  who suggest that endogenous adrenergic 
receptors are involved in the regulation of respiratory system inflammation induced by 
bacterial infection and ensuing increase in cAMP in this case which suggest that octopamine 
and octopamine receptors may be involved in  the tracheal innate immunity. 
My results reveal that many organs in Drosophila  larvae which launch an immune response 
including the barrier epithelia ( intestine, salivary gland and malpighian tubules) show OARs 
and TARs expression. I found that all tyramine receptors and one octopamine receptors 
namely the oa2 show expression in gut cells and also I observed strong expression of TyrRIII 
and oa2 in malpighian tubule. The presence of tyramine in malpighian tubule was reported by 
Cole et al. (2005) that the malpighian tubules contain tyrosine decarboxylase which converts 
tyrosine into tyramine. Taken together, my results suggest that octopamine and tyramine 
receptors may be involved in epithelial innate immunity response. 
Feeding behaviour in Drosophila is neuronally anchored (Melcher et al., 2007). In our results 
we found that TyrR is expressed in the adult Drosophila proboscis especially the two labellae 
and their psuedotrachea, which suggest the role of TyrR in the gustatory behaviour. This 
confirmed the results reported by Pospisilik et al. (2010), who suggested that TyrR plays a 
direct role in nutrient sensing by odorant/gustatory network. In our results, we reported a 
novel physiological character for Oamb, strong expression in the branching pattern of the 
tracheal system including a lot of visceral branches and transverse connectives in Oamb-
GAL4/UAS::GFP larvae was seen which were visible through the cuticle of living larvae. In 
Drosophila, three levels of tracheal branching : six primary branches formed first, followed 
by about 20 secondary branches and hundreds or more terminal branches in each 
hemisegment. Each of the three levels of tracheal branching appear to involve different 
cellular mechanisms and different sets of tracheal genes and the development of the tracheal 
system occurs by a series of branching events and these genes regulates the different steps of 
branching (Samakovlis et al., 1996). Perhaps Oamb is involved in the tracheal branching 
process. 
 
4.2. Dopaminergic receptors 
In both vertebrates and invertebrates, the biogenic amine dopamine is implicated in many 
functions including locomotion, cognition, and development (Civelli, 1993) Furthermore, 
misregulation of dopamine signaling is believed to play a role in a number of human disorders 
including schizophrenia, Parkinson’s disease, Tourette’s syndrome, and drug addiction. The 
actions of dopamine are mediated via G protein–coupled receptors (GPCRs). Dopamine 
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receptors are members of the rhodopsin-like family of GPCRs (Jackson and Westlind-
Danielsson, 1994). 
Drosophila dopamine receptors belong to three groups: DopR1 group or DmDop1, also 
known as dDA1 (Gotzes et al., 1994; Sugamori et al., 1995); DAMB or DopR2 group(Feng et 
al., 1996; Han et al., 1996) ; and D2-like receptor, also called D2R (Hearn et al., 2002). 
Biosynthesis of dopamine starts from amino acid, tyrosine which converts to 
dihydroxyphenylalanine (L-DOPA) by the enzyme tyrosine hydroxylase. Dopa decarboxylase 
enzyme then catalyzes the conversion of L-DOPA to dopamine.  
I try in this study  to explore the dopamine receptors; DopR, DopR2 localization of each 
receptor in neuronal and nonneuronal tissues in both larval and adult stages. To achieve this, 
the GAL4/UAS bipartite system with GFP as a reporter was used.  
This study demonstrates distinct expression of DopR2 and D2R in the tracheal system of 
larvae in the three major parts of the tracheal system; the primary airways, the secondary 
airways, and the blind ending terminal ones. Enrichment of DA in the trachea was reported 
earlier  (Hsouna et al., 2007). DA pathway mutants show dramatic effects on the stereotyped 
migratory behaviour of tracheal cells and patterning of the resulting branched structure and 
those abnormalities could be rescued by DA treatment. Consistently, genes involved in DA 
biosynthesis also regulate tracheal migration.  
In this study, immunohistochemistry with three different primary antisera; anti-GFP, anti-
prospero which labelling entroendocrine cells (Campbell et al., 1994) and anti-armadillo 
which label diploid and polyploid enterocytes that lack prospero (Riggleman et al., 1990) was 
done to label specifically enterocytes. Most of enteroendocrine cells, which express the 
transcription factor prospero and also the ß-catenin homologue Armadillo, express also DopR. 
Entroendocrine, or neuroendocrine, cells secrete peptide hormones to coordinate 
gastrointestinal functions, such as motility and secretion  (Schonhoff et al., 2004). 
My study demonstrates a novel expression pattern of the DopR in larval and adult CNS except 
few brain structures which were reported before for DmDOP1 receptor expression. In larval 
CNS, the GFP appeared as mesh-like connected bundles where somata are located on almost 
all neuropile secondary traces including; medial dorsoposterior, lateral dorsoanterior, medial 
dorsoanterior, lateral dorsoposterior traces which are located dorsally in each hemisphere; 
centromedial and centroposterior which are located in the centre of the neuropile; basolateral 
anterior, basolateral ventral and basolateral posterior traces in the base of each brain 
hemisphere and these somata were connected by secondary small axon traces travelling  
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radially within the hemisphere. Strongly expressed somata were also seen  in the thoracico-
abdominal ganglion but also connected by short axons giving the same mesh-like appearance. 
In the adult brain, the DopR positive clusters were seen almost everywhere in the supra- and 
subesophageal ganglia as well as in the optic lobes. Mushroom body substructures were 
reported to express dopaminergic receptors  with relatively stronger staining in the mushroom 
body γ lobe/ heel, according to other studies, this structure implicated in the short- term 
memory formation (Zars et al., 2000) and less staining was seen  in α/ß and α´/ß´ lobes. This 
fits well with the results reported by Kim et al. (2003) Within the interhemispheric junction, 
strong GFP expression was seen in the central complex substructures including; the outer 
margin of the fan-shaped body; some positive DopR neurons including somata which 
innervate the ellipsoid body; noduli and some axonal projections connecting the central 
complex substructures. Pervious studies suggested the critical role of the central complex in 
the motor control, olfactory conditioning, courtship and functional tolerance of alcohol 
(Heisenberg et al., 1985; Strauss and Heisenberg, 1993; Bausenwein et al., 1994; Scholz et 
al., 2000). Also in adult brain, a dense ramification was seen in the superior and inferior 
posterior slope surrounding the esophageal foramen. Strong GFP expression was seen in the 
optic lobe including lobula, lobula plate and inner- and outer medulla. Two large somata were 
seen in the ventro-medial part of the subesophageal ganglion. DopR positive neurons project 
from posterior inferior lateral protocerebrum into the ventromedial protocerebrum. In 
addition, DopR positive neurons project from posterior inferior lateral protocerebrum towards 
the midline. Strongly expressing somata are also located in the lateral protocerebrum and in 
the ventrolateral part of the antennal lobe and antennal nerve. A cluster of strong expressed 
somata located in the ventrolateral protocerebrum. Positive DopR neurons ramified bilaterally 
in the ventromedial protocerebrum, they have their somata located on the midline of the 
subesophageal ganglion with mirror symmetry. They can be divided into three neuromeres 
(mandibular, maxillary, and labial) in the gnathal segment. Therefore, these subclusters are 
named VMmd, VMmx and VMlb from anterior to posterior. The GFP expression is strong in 
both VMmx and VMlb but it is moderate in the VMmd cluster. The secondary neurons turn 
ventrally to descend through the cervical connective. These descending axons terminate in all 
three thoracic ganglia and abdominal ganglia. The expression within the thoracicoabdominal 
ganglia was reported by Kim et al. (2003). 
This study demonstrates the D2R expression pattern in both larval and adult CNS. In the 
larval CNS, moderate GFP was seen in mushroom body substructures including: b /b´ lobes, 
GFP expression pattern in the α/α´ lobes was seen as a cap over the lobes and GFP expression 
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appears as a cap over the calyx of mushroom body. Somata and projections were seen allover 
the brain hemisphere. Strongly expressing somata were seen in the thoracicoabdominal 
ganglia along the midline, they send transverse projections toward the dorsolateral trace and 
some of their projections come out of the brain to the periphery. These abdominal projections 
which send projections laterally toward the outer edges of the neuropile and D2R longitudinal 
traces that run parallel on either side of the midline were reported before by Draper et al. 
(2007).   
D2R expression was seen in the larval eye anlagen. The eye anlage remains part of the surface 
epithelium until later in embryogenesis, giving rise to the cortices of the lamina and the distal 
medulla (Meinertzhagen, 1993). 
In adult CNS, Mushroom body substructures could not be distinguished. D2R positive 
projections appear as a net of fibers observed throughout the hemispheres. These projection 
were seen before by Draper et al. (2007). In this study, some positive stained projections 
adjacent to the mushroom body were identified. This huge number of projections appears as a 
net of fibers observed throughout the hemispheres. This characteristic immunoreactivity was 
reported also by Draper et al. (2007). This large network of D2R neurons may suggest that 
D2R projections serve as neural circuits linking the central complex with the mushroom body 
and antennal lobe to facilitate the flow of informations 
Results in this study demonstrate that D2R expression was highly enriched in larval salivary 
gland, esophagus, pharynx, pharyngeal muscles and muscular stripes of the hindgut but 
midgut cells did not show detectable D2R which conflicts with the results obtained by Draper 
et al. (2007) who demonstrate the D2R in some of the midgut cells but not in the salivary 
glands, esophagus and  proventriculus. A previous study used reverse transcription followed 
by quantitative PCR to confirm that the D2R gene is expressed in larvae, pupae, and adults 
(Hearn et al., 2002). 
 
4.3. Pharmacology of octopaminergic receptors 
Performing pharmacological studies is a prerequisite for a detailed analysis of the 
corresponding receptors. Tissue culture systems that allow heterologous expression, such as 
HEK-293 cells are advantageous, because they combine a simple read-out with the occurrence 
of only a single receptor that has to be analyzed.  
In this study, the ability to change intracellular cAMP levels in octopaminergic receptors, 
Lymnaea OA, DmOcß2R and DmOctß3R, in response to exposure to a wide range of naturally 
occurring biogenic amines or known synthetic ligands was tested. My results demonstrated 
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that NC5 and NC7 have higher affinities to Lymnaea OA receptor than synpherine, which in 
turn has a higher affinity than desmethylchlordimeform. The biogenic amines octopamine has 
a higher affinity than dopamine, tyramine and serotonine. The EC50 values were octopamine 
3.03× 10-6 M; Dopamine 1.68× 10-5 M; Tyramine 1,25×10-5 M; Serotonin 1.78×10-4 M. 
Lymaea OA receptor was reported to has a 12,6 –fold higher affinity for octopamine 
compared with tyramine (Gerhardt et al., 1997a; Gerhardt et al., 1997b). Using nervous tissue 
homogenate from  the honey bee Apis mellifera  and from the desert locust Schistocerca 
gregaria (Degen et al., 2000), it was shown that the difference in affinity for octopamine 
versus tyramine were 3.8- and 6,5-fold, respectively.  NC7 was reported as a highly potent 
and specific agonist to OA receptors in insects (Nathanson, 1985; Roeder and Gewecke, 1990; 
Hiripi et al., 1994), and also as a high affinity to Lymnaea OA receptors (Hiripi et al., 1998). 
In the pharmacological characterization of Lymnaea OA receptor antagonists, my study 
demonstrates that yohimbine has the highest affinity to Lymnaea OA receptor followed by 
metoclopramide > phentolamine > rauwolscine > chloromazine > mianserin > epinostine. 
Phentolamine was reported by Hiripi et al. (1998) that it can completely and reversibly block 
the OA effect on Lymnaea OA receptors at concentrations of 10-6M and it is the most 
effective substance to inhibit the OA response. The antagonists mianserin and phentolamine 
were also reported by Hiripi et al. (1998)  to have higher affinity to Lymnaea OA receptors  
than chlorpromazine and yohimbine.  Parallel to my results, rauwolscine was reported by 
Hiripi et al. (1998) to have high affinity to Lymnaea OA receptors but OA could displace 
rauwolscine only at high concentration range between 0.1-1.0 mM. 
The presence of OA-immunopositive neurons and fibres in Lymaea brain was demonstrated 
(Elekes et al., 1993).  
DmOcß2R and DmOctß3R are members of functional selective octopamine receptors that are 
coupled to increase in cAMP levels.  They are named ß-receptors as they show structural 
similarities with vertebrate ß-adrenergic  receptors (Maqueira et al., 2005). The most effective 
naturally occurring ligands at increasing cAMP levels are octopamine, tyramine and 
synpherine, this was also demonstrated by Maqueira et al. (2005) but my results demonstrate 
that  the  rank order of potency for biogenic amines octopamine and tyramine was different 
for octß2R and octß3R receptors (EC50: Octß2R  tyramine > octopamine,  Octß3R  
octopamine > tyramine). 
In my results, the rank order of potency for the active synthetic agonists tested was the same 
for both  receptors (EC50s : Naphazoline > octopamine), while  Maqueira et al. (2005) 
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reported that the rank of potency for both agonists was different for these receptors (EC50s : 
Octß2R octopamine > Naphazoline,  Octß3R   Naphazoline > octopamine).  
Phentolamine , a classical a-adrenergic  antagonists  was able to increase the cAMP in the 
transfected cells, as well as able to block the octopamine mediated increase in cAMP.  
Phentolamine acts as a partial agonist of this response at the Octß2R and Octß3R.  The 
efficacy for this response is more in Ocß2R > Octß3R (Maqueira et al., 2005). 
This pharmacological characterization opens the possibility to develop new types of ligands 
that specifically interact with only one subtype and that might serve as lead structures for the 
development of new insecticides in the future.                         
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 5. Summary 
 
The main goal of this work was to explore the functional relevance of selected receptors for 
biogenic amines in the fruit fly Drosophila melanogaster and to find those candidates that 
may be suited to function as targets for new types of insecticides. I focussed on the receptors 
for octopamine (OARs), tyramine (TARs) and dopamine (DARs). Therefore, I mapped the 
expression of the corresponding receptor genes throughout all developmental stages and in all 
organs in the fruit fly. For selected receptors, these results were supplemented by 
pharmacological studies. In addition, RNAi-mediated gene silencing was used to identify 
phenotypical changes associated with this loss of gene expression.  
All DARs show a widespread expression within the central nervous system of the fly and all 
of them show a particularly strong expression in the mushroom bodies, centres for learning 
and memory in the insect brain. Regarding the TARs a more complex expression profile 
became apparent. Most importantly, TyrR is the sole OAR/TAR receptor that is present in the 
heart of the fly. In addition, it shows very high expression in the major insulin-producing cells 
and in oenocytes of larvae and adults, suggesting that TyrR might be relevant for controlling 
the lipid metabolism of the fly. Amongst the OARs, oa2 show an almost ubiquitous 
expression in the nervous system, whereas its expression in non-neuronal tissues is only 
moderate. Regarding the expression in muscles, Ocß2R is present in the entire muscle system 
of larvae and in walking muscles of adults. In the leg, the pattern of expression is 
complementary to that of the Oamb. TyrR, as the most relevant representative of TARs, also 
show expression in muscles; namely in (1) the segmentally repeated ventral longitudinal 
muscles which play a major part of larval crawling, (2) lateral longitudinal muscles, and (3) 
lateral oblique muscles in each body hemisegments from the head to the tail region. I 
concentrated for the functional studies on the Ocß2R receptor and found, using RNAi-
mediated gene silencing some very interesting phenotypical changes. I recorded muscle 
weakness during walking and the inability of adults to go up a vertical surface against the 
gravity, which caused no problems for wild type flies. More over, during courtship, males 
were not able to keep up with females, which leads to failures of the entire behaviour. 
Consequently, these flies are sterile.  
Pharmacological features of octopamine receptors were quantified using heterologous 
expression of the corresponding receptors (OARs) in HEK293 cells. The general 
pharmacological features of all OARs tested have striking similarities. These similarities 
could even be observed, if a corresponding receptor of the snail Lymnaea stagnalis was 
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included, indicating a very high conservation of pharmacological features among OARs 
throughout the invertebrates. Nevertheless, distinct peculiarities of the different OARs from 
the fly could be observed. This pharmacological characterization opens the possibility to 
develop new types of ligands that specifically interact with only one subtype and that might 
serve as lead structures for the development of new insecticides in the future.  
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Zusammenfassung 
 
Das Hauptziel dieser Arbeit bestand darin, die physiologische Relevanz ausgewählter 
Rezeptoren für biogene Amine der Fruchtfliege Drosophila melanogaster aufzuklären. 
Basierend auf diesen Arbeiten sollten Rezeptoren identifiziert werden, die als Angriffsort 
neuer Insektizide dienen könnten. Hierfür habe ich mich auf die Rezeptoren für Octopamin 
(OARs), Tyramin (TARs) und Dopamin (DARs) konzentriert. Ich habe das 
Expressionsmuster dieser Rezeptorgene, sowohl bei Larven als auch bei Adulten, detailliert 
analysiert. Für einige dieser Rezeptoren (OARs) wurden weiterführende pharmakologische 
Studien durchgeführt. Außerdem wurde die physiologische Bedeutung eines besonders 
interessanten Rezeptors mittels des RNAi vermittelten gene silencings aufgeklärt.  
Alle DARs zeigen eine relativ weiträumige Expression im Nervensystem sowohl larvaler als 
auch adulter Fliegen. Besonders hervorzuheben ist hierbei die besonders starke Expression in 
den sog. Pilzkörpern, die als Orte der Gedächtnisbildung bei Insekten gelten. Die TARs 
hingegen zeigen ein etwas komplexeres Expressionsmuster, das geringere Überschneidungen 
zwischen den vier Mitgliedern dieser Gruppe zeigt. TyrR ist der einzige Rezeptor aus der 
Gruppe der OARs/TARs, der im Herzen der Fliege exprimiert wird. Außerdem wird dieser 
Rezeptor besonders stark in den Insulin-produzierenden Zellen sowie in den Oenozyten, den 
funktionalen Äquivalenten der Leber, exprimiert. Das lässt vermuten, dass dieser Rezeptor für 
die Regulation des Fettstoffwechsels von ganz entscheidender Bedeutung ist.  Unter den 
OARs, weist der oa2 eine besonders breite Expression im Nervensystem von Larven und 
Adulten auf. Hingegen ist die Expression dieses Rezeptorgens in nicht-neuronalen Geweben 
eher schwach. In Bezug auf die Expression in Muskeln sticht insbesondere der Ocß2R 
Rezeptor hervor. Bei Larven kann dieser Rezeptor in allen Muskeln nachgewiesen werden, 
bei Adulten in der Muskulatur, die für das Gehen verantwortlich ist. Im Bein ist das 
Expressionsmuster komplementär zu dem des Oamb-Gens. TyrR, als wichtigster Vertreter der 
Tyraminrezeptoren kommt auch in einigen Muskeln vor, z.B. in ventralen 
Longitudinalmuskeln der Larve sowie in einigen, segmental angeordneten Lateralmuskeln. 
Für die funktionelle Analyse habe ich mich auf den Ocß2R Rezeptor konzentriert. Mittels der 
RNAi-vermittelten gene silencing konnte ich zeigen, dass die betroffenen Tiere eine 
ausgeprägte Muskelschwäche aufwiesen. Adulte haben die Befähigung verloren eine 
senkrechte Fläche hinaus zu krabbeln, eine Aufgabe, die von Wildtypen ohne Weiteres 
bewältigt wird. Außerdem zeigten sie Defizite im Paarungsverhalten was offensichtlich auf 
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der Unfähigkeit des Männchens beruhte, dem Weibchen in der erforderlichen stereotypen 
Weise zu folgen. Daraus ergab sich eine auffällige Sterilität dieser Fliegen.  
Die pharmakologischen Charakteristika einiger Octopaminrezeptoren habe ich mittels 
heterologer Expression in HEK-Zellen evaluiert. Es zeigte sich, dass die generellen 
pharmakologischen Eigenschaften der unterschiedlichern OARs größere Gemeinsamkeiten 
aufweisen. Diese Gemeinsamkeiten waren sogar noch dann deutlich, wenn ein homologer 
Rezeptor aus der Schnecke Lymnea stagnalis in die Untersuchungen miteinbezogen wurde, 
was darauf hindeutet, dass wesentliche Charakteristika dieser Rezeptoren über die gesamte 
Gruppe der Wirbellosen hinweg konserviert sind. Trotzdem, konnten ich pharmakologische 
Unterschiede ausmachen, die zur eindeutigen Unterscheidung dieser Rezeptoren dienen und 
die letztlich dazu dienen könnten, neuartige Leitstrukturen für die Entwicklung von 
Insektiziden zu entwickeln.  
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